EP1527182A2 - Methode de production d'acides gras insatures - Google Patents
Methode de production d'acides gras insaturesInfo
- Publication number
- EP1527182A2 EP1527182A2 EP03716183A EP03716183A EP1527182A2 EP 1527182 A2 EP1527182 A2 EP 1527182A2 EP 03716183 A EP03716183 A EP 03716183A EP 03716183 A EP03716183 A EP 03716183A EP 1527182 A2 EP1527182 A2 EP 1527182A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- desaturase
- seq
- fatty acid
- plant
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 92
- 230000008569 process Effects 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 18
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 18
- 230000014509 gene expression Effects 0.000 claims abstract description 65
- 238000003259 recombinant expression Methods 0.000 claims abstract description 56
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 53
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 48
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 46
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 41
- 230000009261 transgenic effect Effects 0.000 claims abstract description 35
- 241000238631 Hexapoda Species 0.000 claims abstract description 27
- 241000255777 Lepidoptera Species 0.000 claims abstract description 17
- 241000195493 Cryptophyta Species 0.000 claims abstract description 16
- 241000233866 Fungi Species 0.000 claims abstract description 13
- 241000196324 Embryophyta Species 0.000 claims description 168
- 150000007523 nucleic acids Chemical group 0.000 claims description 93
- 239000000194 fatty acid Substances 0.000 claims description 91
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 88
- 229930195729 fatty acid Natural products 0.000 claims description 88
- 150000004665 fatty acids Chemical class 0.000 claims description 83
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 55
- 230000000694 effects Effects 0.000 claims description 33
- 108010087894 Fatty acid desaturases Proteins 0.000 claims description 30
- 102000009114 Fatty acid desaturases Human genes 0.000 claims description 29
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 17
- 240000002791 Brassica napus Species 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 15
- 239000013604 expression vector Substances 0.000 claims description 14
- 150000003626 triacylglycerols Chemical class 0.000 claims description 14
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 10
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 9
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 9
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 claims description 9
- 235000004426 flaxseed Nutrition 0.000 claims description 9
- 240000006240 Linum usitatissimum Species 0.000 claims description 8
- 244000299461 Theobroma cacao Species 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 7
- 244000105624 Arachis hypogaea Species 0.000 claims description 7
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 7
- 235000018262 Arachis monticola Nutrition 0.000 claims description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims description 7
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 7
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 7
- 235000020232 peanut Nutrition 0.000 claims description 7
- 241000580885 Cutaneotrichosporon curvatus Species 0.000 claims description 6
- 235000001950 Elaeis guineensis Nutrition 0.000 claims description 6
- 241000907999 Mortierella alpina Species 0.000 claims description 6
- 241000306281 Mucor ambiguus Species 0.000 claims description 6
- 240000000528 Ricinus communis Species 0.000 claims description 6
- 235000004443 Ricinus communis Nutrition 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 6
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 5
- 244000060011 Cocos nucifera Species 0.000 claims description 5
- 241000197220 Pythium insidiosum Species 0.000 claims description 5
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 239000012847 fine chemical Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 108091081021 Sense strand Proteins 0.000 claims description 2
- 230000000692 anti-sense effect Effects 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 240000003133 Elaeis guineensis Species 0.000 claims 3
- 244000020551 Helianthus annuus Species 0.000 claims 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 description 90
- 108090000623 proteins and genes Proteins 0.000 description 79
- 102100021023 Gamma-glutamyl hydrolase Human genes 0.000 description 68
- 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 68
- 239000013598 vector Substances 0.000 description 63
- 108020004635 Complementary DNA Proteins 0.000 description 44
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 37
- 238000010804 cDNA synthesis Methods 0.000 description 34
- 239000002299 complementary DNA Substances 0.000 description 33
- 230000009466 transformation Effects 0.000 description 31
- 108020004414 DNA Proteins 0.000 description 30
- 239000013612 plasmid Substances 0.000 description 27
- 102000004169 proteins and genes Human genes 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 24
- 239000002609 medium Substances 0.000 description 23
- 239000000758 substrate Substances 0.000 description 20
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 150000001413 amino acids Chemical group 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 17
- 102000039446 nucleic acids Human genes 0.000 description 17
- 239000003016 pheromone Substances 0.000 description 17
- 241000589158 Agrobacterium Species 0.000 description 16
- 150000002632 lipids Chemical class 0.000 description 16
- 241000894007 species Species 0.000 description 16
- 230000002068 genetic effect Effects 0.000 description 15
- 210000004907 gland Anatomy 0.000 description 15
- -1 phosphatidyl cholins Chemical class 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 14
- 241000721451 Pectinophora gossypiella Species 0.000 description 14
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 14
- 238000010367 cloning Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000013615 primer Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 12
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 11
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical class CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 9
- 238000001400 expression cloning Methods 0.000 description 9
- 238000004817 gas chromatography Methods 0.000 description 9
- 235000020778 linoleic acid Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 235000021588 free fatty acids Nutrition 0.000 description 8
- 239000004009 herbicide Substances 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 238000009396 hybridization Methods 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- 241000208818 Helianthus Species 0.000 description 7
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 238000002703 mutagenesis Methods 0.000 description 7
- 231100000350 mutagenesis Toxicity 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 101710180133 Acyl-CoA Delta(11) desaturase Proteins 0.000 description 6
- 241000918644 Epiphyas postvittana Species 0.000 description 6
- 108090000769 Isomerases Proteins 0.000 description 6
- 102000004195 Isomerases Human genes 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- 241001147398 Ostrinia nubilalis Species 0.000 description 6
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 6
- 241000209140 Triticum Species 0.000 description 6
- 235000021307 Triticum Nutrition 0.000 description 6
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 241000208838 Asteraceae Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 241000255967 Helicoverpa zea Species 0.000 description 5
- 241000227653 Lycopersicon Species 0.000 description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 description 5
- 244000061456 Solanum tuberosum Species 0.000 description 5
- 241000030538 Thecla Species 0.000 description 5
- 241000255993 Trichoplusia ni Species 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000012411 cloning technique Methods 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000009973 maize Nutrition 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 108010058731 nopaline synthase Proteins 0.000 description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 210000001995 reticulocyte Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- DQGMPXYVZZCNDQ-KBPWROHVSA-N (8E,10E,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C=C/C=C/CCCCCCC(O)=O DQGMPXYVZZCNDQ-KBPWROHVSA-N 0.000 description 4
- DJCQJZKZUCHHAL-UHFFFAOYSA-N (Z)-9-Pentadecensaeure Natural products CCCCCC=CCCCCCCCC(O)=O DJCQJZKZUCHHAL-UHFFFAOYSA-N 0.000 description 4
- 241001525898 Argyrotaenia velutinana Species 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- 241000255789 Bombyx mori Species 0.000 description 4
- 241000195940 Bryophyta Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- 108010068370 Glutens Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000012159 carrier gas Substances 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- UWHZIFQPPBDJPM-FPLPWBNLSA-N cis-vaccenic acid Chemical compound CCCCCC\C=C/CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-FPLPWBNLSA-N 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 235000021186 dishes Nutrition 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000002363 herbicidal effect Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 3
- 235000011331 Brassica Nutrition 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 241000219193 Brassicaceae Species 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 241000219321 Caryophyllaceae Species 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- 241000218631 Coniferophyta Species 0.000 description 3
- 239000003155 DNA primer Substances 0.000 description 3
- 244000127993 Elaeis melanococca Species 0.000 description 3
- 241000393496 Electra Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000730161 Haritalodes derogata Species 0.000 description 3
- 241000122115 Hemileuca Species 0.000 description 3
- 241000413130 Hemileuca eglanterina Species 0.000 description 3
- 241000912701 Hemileuca electra Species 0.000 description 3
- 241000413125 Hemileuca electra mojavensis Species 0.000 description 3
- 241000208202 Linaceae Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 241000219071 Malvaceae Species 0.000 description 3
- 241000255908 Manduca sexta Species 0.000 description 3
- 241000219823 Medicago Species 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 241000346285 Ostrinia furnacalis Species 0.000 description 3
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 3
- 241000235648 Pichia Species 0.000 description 3
- 241000918651 Planotortrix octo Species 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 241000209056 Secale Species 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 241000208292 Solanaceae Species 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 241000192584 Synechocystis Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 244000038559 crop plants Species 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 3
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000006317 isomerization reaction Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 235000014571 nuts Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 230000001177 retroviral effect Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- IJTNSXPMYKJZPR-ZSCYQOFPSA-N (9Z,11E,13E,15Z)-octadecatetraenoic acid Chemical compound CC\C=C/C=C/C=C/C=C\CCCCCCCC(O)=O IJTNSXPMYKJZPR-ZSCYQOFPSA-N 0.000 description 2
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 2
- PYJMGUQHJINLLD-UHFFFAOYSA-N 2-(7-methoxynaphthalen-1-yl)acetonitrile Chemical compound C1=CC=C(CC#N)C2=CC(OC)=CC=C21 PYJMGUQHJINLLD-UHFFFAOYSA-N 0.000 description 2
- MBPFNOMGYSRGQZ-PBXRRBTRSA-N 2-deoxy-D-glucose 6-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)CC=O MBPFNOMGYSRGQZ-PBXRRBTRSA-N 0.000 description 2
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 2
- NPDSHTNEKLQQIJ-SIGMCMEVSA-N 9-hode Chemical compound CCCCC\C=C\C=C\C(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-SIGMCMEVSA-N 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 2
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 108010018763 Biotin carboxylase Proteins 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- 241000255794 Bombyx mandarina Species 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- 101000801225 Choristoneura rosaceana Acyl-CoA Delta(11) desaturase Proteins 0.000 description 2
- 241000413105 Coloradia velda Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000219112 Cucumis Species 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000208175 Daucus Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 description 2
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 description 2
- 241001012951 Diaphania nitidalis Species 0.000 description 2
- 241000122106 Diatraea saccharalis Species 0.000 description 2
- 241000937979 Dioryctria abietella Species 0.000 description 2
- 241000195634 Dunaliella Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000353522 Earias insulana Species 0.000 description 2
- 241000776776 Epiplema Species 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- 241001634830 Geometridae Species 0.000 description 2
- 241000208152 Geranium Species 0.000 description 2
- 108010061711 Gliadin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101710091951 Glycerol-3-phosphate acyltransferase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 241000219146 Gossypium Species 0.000 description 2
- 241000168525 Haematococcus Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- 241000208822 Lactuca Species 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 235000002262 Lycopersicon Nutrition 0.000 description 2
- 241000196323 Marchantiophyta Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000256259 Noctuidae Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000002725 Olea europaea Nutrition 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 101150101414 PRP1 gene Proteins 0.000 description 2
- 241000255947 Papilionidae Species 0.000 description 2
- 240000007377 Petunia x hybrida Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108030002884 Phosphinothricin acetyltransferases Proteins 0.000 description 2
- 108030002650 Phospholipid:diacylglycerol acyltransferases Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 241000219843 Pisum Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000255893 Pyralidae Species 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000220222 Rosaceae Species 0.000 description 2
- 241001107098 Rubiaceae Species 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- 235000002634 Solanum Nutrition 0.000 description 2
- 241000207763 Solanum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 241000255901 Tortricidae Species 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 241000195615 Volvox Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 108010057084 acyl-CoA delta10-desaturase Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 2
- IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 2
- 238000012197 amplification kit Methods 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 229960001561 bleomycin Drugs 0.000 description 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- NPDSHTNEKLQQIJ-UHFFFAOYSA-N dimorphecolic acid Natural products CCCCCC=CC=CC(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000004345 fruit ripening Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002337 glycosamines Chemical class 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 108010002685 hygromycin-B kinase Proteins 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000008121 plant development Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940055019 propionibacterium acne Drugs 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000010187 selection method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 108010008664 streptomycin 3''-kinase Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000012250 transgenic expression Methods 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- LGHXTTIAZFVCCU-SSVNFBSYSA-N (2E,4E,6E,8E)-octadeca-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O LGHXTTIAZFVCCU-SSVNFBSYSA-N 0.000 description 1
- ZUUFLXSNVWQOJW-MBIXAETLSA-N (2e,4e,6e)-octadeca-2,4,6-trienoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C(O)=O ZUUFLXSNVWQOJW-MBIXAETLSA-N 0.000 description 1
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- YPELFRMCRYSPKZ-UHFFFAOYSA-N 4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide Chemical compound CCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1OCCN(CC=2C=CC(F)=CC=2)C1 YPELFRMCRYSPKZ-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- QUTYKIXIUDQOLK-PRJMDXOYSA-N 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid Chemical compound O[C@H]1[C@H](OC(=C)C(O)=O)CC(C(O)=O)=C[C@H]1OP(O)(O)=O QUTYKIXIUDQOLK-PRJMDXOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 1
- 101710197633 Actin-1 Proteins 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 102000000665 Acyl-CoA desaturases Human genes 0.000 description 1
- 101150021974 Adh1 gene Proteins 0.000 description 1
- 241000175828 Adoxophyes orana Species 0.000 description 1
- 241001110888 Advenella Species 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 241000370472 Agaristinae Species 0.000 description 1
- 235000016626 Agrimonia eupatoria Nutrition 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 241001420348 Amorbia cuneana Species 0.000 description 1
- 241001044370 Amphion floridensis Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000132389 Andraca Species 0.000 description 1
- 241001212647 Anisodes Species 0.000 description 1
- 241000207875 Antirrhinum Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000208306 Apium Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000218157 Aquilegia vulgaris Species 0.000 description 1
- 108700021822 Arabidopsis oleosin Proteins 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241001415070 Arctiinae Species 0.000 description 1
- 241001203923 Argyresthia Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001106067 Atropa Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101000755953 Bacillus subtilis (strain 168) Ribosome maturation factor RimP Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001116272 Balsaminaceae Species 0.000 description 1
- 241000223679 Beauveria Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000580525 Berzelia albiflora Species 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000255783 Bombycidae Species 0.000 description 1
- 101000972350 Bombyx mori Lebocin-4 Proteins 0.000 description 1
- 241001573600 Bradina Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000005489 Bromoxynil Substances 0.000 description 1
- 241000209200 Bromus Species 0.000 description 1
- 241001201735 Bryotropha Species 0.000 description 1
- 241000512035 Bryotropha terrella Species 0.000 description 1
- 241000605902 Butyrivibrio Species 0.000 description 1
- 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 1
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241001184747 Caloptilia theivora Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241001347514 Carposinidae Species 0.000 description 1
- 229940123363 Cathepsin D inhibitor Drugs 0.000 description 1
- 244000097582 Cecropia peltata Species 0.000 description 1
- 241000871189 Chenopodiaceae Species 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 241000723343 Cichorium Species 0.000 description 1
- 241000223782 Ciliophora Species 0.000 description 1
- 108010061190 Cinnamyl-alcohol dehydrogenase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000007460 Coffea arabica Nutrition 0.000 description 1
- 241000228031 Coffea liberica Species 0.000 description 1
- 241000248395 Colpidium Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001105410 Cossidae Species 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 241000199913 Crypthecodinium Species 0.000 description 1
- 241001587415 Cryptoblabes gnidiella Species 0.000 description 1
- 241000918694 Ctenopseustis filicis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 241000592295 Cycadophyta Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 241000794664 Deilephila elpenor Species 0.000 description 1
- 235000002845 Dianthus plumarius Nutrition 0.000 description 1
- 241001000394 Diaphania hyalinata Species 0.000 description 1
- 241000879145 Diatraea grandiosella Species 0.000 description 1
- 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 241001108096 Dioryctria clarioralis Species 0.000 description 1
- 241001589579 Dioryctria merkeli Species 0.000 description 1
- 241001589580 Dioryctria resinosella Species 0.000 description 1
- 241001108109 Dioryctria rubella Species 0.000 description 1
- 241001572697 Earias vittella Species 0.000 description 1
- 241001480508 Entomophthora Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241001465321 Eremothecium Species 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 241000131749 Eriocraniidae Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- 240000002395 Euphorbia pulcherrima Species 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 241000063646 Eurhodope Species 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 241000220223 Fragaria Species 0.000 description 1
- 241000597000 Freesia Species 0.000 description 1
- 101710196411 Fructose-1,6-bisphosphatase Proteins 0.000 description 1
- 101710186733 Fructose-1,6-bisphosphatase, chloroplastic Proteins 0.000 description 1
- 101710109119 Fructose-1,6-bisphosphatase, cytosolic Proteins 0.000 description 1
- 101710198902 Fructose-1,6-bisphosphate aldolase/phosphatase Proteins 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000753131 Gelechia Species 0.000 description 1
- 241001454728 Gelechiidae Species 0.000 description 1
- 241000752715 Gelechiinae Species 0.000 description 1
- 241000208150 Geraniaceae Species 0.000 description 1
- 241001112537 Gesneriaceae Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 description 1
- 241000410838 Gracillariidae Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101150031823 HSP70 gene Proteins 0.000 description 1
- 241001435779 Helcystogramma macroscopa Species 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 241000209219 Hordeum Species 0.000 description 1
- 241000794682 Hyles gallii Species 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000015912 Impatiens biflora Nutrition 0.000 description 1
- 235000003361 Impatiens capensis Nutrition 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 241000284389 Jodis lactearia Species 0.000 description 1
- 241000758789 Juglans Species 0.000 description 1
- 235000013757 Juglans Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000255679 Lasiocampidae Species 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 241000086074 Leucinodes orbonalis Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 241000193982 Loxostege Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001124569 Lycaenidae Species 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- 241001124557 Lymantriidae Species 0.000 description 1
- 241001190778 Lyonetiidae Species 0.000 description 1
- 101150050813 MPI gene Proteins 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000121629 Majorana Species 0.000 description 1
- 241000732113 Mamestra configurata Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 241000427649 Melongena Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 101100409013 Mesembryanthemum crystallinum PPD gene Proteins 0.000 description 1
- 240000001140 Mimosa pudica Species 0.000 description 1
- 235000016462 Mimosa pudica Nutrition 0.000 description 1
- 241001531279 Mnesictena Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241001162910 Nemesia <spider> Species 0.000 description 1
- 241000595635 Nepticulidae Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 108010033272 Nitrilase Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000483387 Nola confusalis Species 0.000 description 1
- 241000076410 Notocelia incarnatana Species 0.000 description 1
- 241000035140 Notocelia uddmanniana Species 0.000 description 1
- 241001521301 Notodontidae Species 0.000 description 1
- 241001465805 Nymphalidae Species 0.000 description 1
- 241000567781 Oecophoridae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000219830 Onobrychis Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001147397 Ostrinia Species 0.000 description 1
- 241000130836 Palpita unionalis Species 0.000 description 1
- 241000209117 Panicum Species 0.000 description 1
- 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
- 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
- 241000220435 Papilionoideae Species 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 241000208181 Pelargonium Species 0.000 description 1
- 241000209046 Pennisetum Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000206731 Phaeodactylum Species 0.000 description 1
- 241000506297 Phalonidia manniana Species 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 244000278530 Philodendron bipinnatifidum Species 0.000 description 1
- 235000018976 Philodendron bipinnatifidum Nutrition 0.000 description 1
- 241000720470 Phyllonorycter Species 0.000 description 1
- 241001525612 Phyllonorycter coryli Species 0.000 description 1
- 241000633354 Phyllonorycter crataegella Species 0.000 description 1
- 241001525606 Phyllonorycter harrisella Species 0.000 description 1
- 241001190782 Phyllonorycter ringoniella Species 0.000 description 1
- 241001525771 Phyllonorycter saportella Species 0.000 description 1
- 241001520969 Phyllonorycter sylvella Species 0.000 description 1
- 101710173432 Phytoene synthase Proteins 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241000255964 Pieridae Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- 241000500441 Plutellidae Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241001582367 Polia Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 101710136733 Proline-rich protein Proteins 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000540097 Pseudexentera spoliana Species 0.000 description 1
- 241000333692 Psychidae Species 0.000 description 1
- 241001105477 Pterophoridae Species 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 241000220259 Raphanus Species 0.000 description 1
- 101100368710 Rattus norvegicus Tacstd2 gene Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241001667663 Rondotia menciana Species 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 101100342406 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PRS1 gene Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 244000070968 Saintpaulia ionantha Species 0.000 description 1
- 241001106018 Salpiglossis Species 0.000 description 1
- 241000255975 Saturniidae Species 0.000 description 1
- 241000220151 Saxifragaceae Species 0.000 description 1
- 241000305562 Sceliodes cordalis Species 0.000 description 1
- 241001249127 Scirpophaga Species 0.000 description 1
- 241000665053 Scirpophaga nivella Species 0.000 description 1
- 241001491813 Scopula Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 241000661449 Sesamia grisescens Species 0.000 description 1
- 241001525902 Sesiidae Species 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 101000959886 Solanum tuberosum Aspartic protease inhibitor 2 Proteins 0.000 description 1
- 101000959868 Solanum tuberosum Aspartic protease inhibitor 8 Proteins 0.000 description 1
- 241000256011 Sphingidae Species 0.000 description 1
- 241001637852 Sphinx drupiferarum Species 0.000 description 1
- 241000484436 Sphinx pinastri Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000931749 Spodoptera descoinsi Species 0.000 description 1
- 241001521235 Spodoptera eridania Species 0.000 description 1
- 241000256247 Spodoptera exigua Species 0.000 description 1
- 241000931754 Spodoptera latifascia Species 0.000 description 1
- 241000256250 Spodoptera littoralis Species 0.000 description 1
- 241000985245 Spodoptera litura Species 0.000 description 1
- 241000681501 Spodoptera triturata Species 0.000 description 1
- 108010039811 Starch synthase Proteins 0.000 description 1
- 241000448016 Stenoma Species 0.000 description 1
- 101710198996 Sucrose-binding protein Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 241000205578 Thalictrum Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 241001312519 Trigonella Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 241000282866 Tubulidentata Species 0.000 description 1
- 101150050575 URA3 gene Proteins 0.000 description 1
- 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 description 1
- 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 241000064168 Xyrosaris lichneuta Species 0.000 description 1
- 241001466336 Yponomeutidae Species 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 241000495395 Zeiraphera canadensis Species 0.000 description 1
- 241000199697 Zygaenidae Species 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- CUXYLFPMQMFGPL-FWSDQLJQSA-N alpha-Eleostearic acid Natural products CCCCC=CC=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-FWSDQLJQSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000003043 biohydrogenation Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000001726 chromosome structure Anatomy 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IXLCRBHDOFCYRY-UHFFFAOYSA-N dioxido(dioxo)chromium;mercury(2+) Chemical compound [Hg+2].[O-][Cr]([O-])(=O)=O IXLCRBHDOFCYRY-UHFFFAOYSA-N 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 101150052825 dnaK gene Proteins 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 239000012869 germination medium Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010050792 glutenin Proteins 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 101150094958 gox gene Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 101150047832 hpt gene Proteins 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 125000005481 linolenic acid group Chemical group 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 235000005739 manihot Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 108090000021 oryzin Proteins 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- SECPZKHBENQXJG-BQYQJAHWSA-N palmitelaidic acid Chemical compound CCCCCC\C=C\CCCCCCCC(O)=O SECPZKHBENQXJG-BQYQJAHWSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 101150113864 pat gene Proteins 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 238000013492 plasmid preparation Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 101150063097 ppdK gene Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108060006613 prolamin Proteins 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 102220277134 rs776745497 Human genes 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 108010050014 systemin Proteins 0.000 description 1
- HOWHQWFXSLOJEF-MGZLOUMQSA-N systemin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H]2N(CCC2)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CCC1 HOWHQWFXSLOJEF-MGZLOUMQSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 101150103279 wip1 gene Proteins 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- the invention relates to processes for the production of unsaturated fatty acids, preferably of conjugated polyunsaturated fatty acids such as conjugated linoleic acid (CLA), by the recombinant expression of desaturases from insects of the order Lepidoptera.
- Expression preferably takes place in an organism selected from the group of the plant organisms, yeasts, fungi and algae.
- recombinant expression cassettes for the recombinant expression of desaturases from insects of the order Lepidoptera and the transgenic organisms transformed with these.
- conjugated unsaturated fatty acids are used widely in the food industry, in animal nutrition, in cosmetics and in the pharmaceutical sector. Especially valuable and sought-after unsaturated fatty acids are what are known as conjugated unsaturated fatty acids. Conjugated polyunsaturated fatty acids are relatively rare in comparison with other polyunsaturated fatty acids. Examples of conjugated fatty acids are the conjugated linoleic acids (CLA; conjugated linoleic acid), ⁇ -parinaric acid (18:4 octadecatetraenoic acid), eleostearic acid (18:3 octadecatrienoic acid), the conjugated linolenic acids, dimorphecolic acid and calendulic acid (see scheme 1 ).
- CLA conjugated linoleic acids
- ⁇ -parinaric acid (18:4 octadecatetraenoic acid
- eleostearic acid 18:3 octadecatrienoic acid
- CLA is a collective term for positional and structural isomers of linoleic acid which are distinguished by a conjugated double bond system starting at carbon atom 8, 9, 10 or 11. Some examples are shown in scheme 2. Geometric isomers exist for each of these positional isomers, that is to say cis-cis, trans-cis, cis-trans, trans-trans.
- the CLA isomers (9Z,11 E)-CLA and (10E,12Z)-CLA are known as the biologically active isomers.
- CLA is found predominantly in foodstuffs of animal origin. High CLA concentrations are found in particular in the meat and in dairy products of ruminants: approx. 3 to 4 mg of CLA g fat in beef and lamb (Chin et al. (1992) J Food Comp Anal 5:185-197) and approx. 3 to 7 mg of CLA/g fat in dairy products (Dhiman et al. (1999) J Dairy Sci 82:2146-56), where (9Z,11 E)-CLA at a concentration of approximately 80% is in each case the predominant isomer. Higher plants only contain traces of CLA, with the two biologically active CLA isomers not having been found in plants to date.
- CLA can be synthesized by alkaline isomerization of linoleic acid.
- Vegetable oils with a high linoleic acid content are predominantly used on an industrial scale, for example sunflower oil, safflower oil. Heating to above 180°C under alkaline conditions catalyzes two reactions:
- CLA oils contain a mixture of various CLA isomers and other saturated and unsaturated fatty acids. Owing to the presence of these biologically inactive and unnatural isomers, laborious purification of the biologically active isomers (9Z,1 1 E) CLA and (10E.12Z) CLA is required, or it must be demonstrated that the isomer mixture does not represent a health hazard for humans and animals. It has hitherto not been possible to produce individual CLA isomers by alkaline isomerization in an economically relevant process. Fractional crystallization makes it possible to concentrate the isomers (9Z,1 1 E)-CLA and (10E,12Z)-CLA, respectively.
- reaction products are usually converted into methyl or ethyl esters so that the natural form of CLA, viz. the free fatty acids or the triacyl glyceride, are not available.
- CLA isomerases convert free linoleic acid into CLA (Cepler and Tove (1967) J Biochem Chem 242:5686-5692).
- linoleic acid predominantly exists in esterified form.
- Lipids such as triacyl glycerides constitute the storage form, while thioesters such as acyl-CoA constitute the active form of the fatty acid.
- Fatty acids with trans double bonds are extremely rare.
- the seed oil of some plants contains fatty acids with double bonds in the trans position.
- an E5-fatty acid has been detected in the seed oil of various Thalictrum species (Rankoff et al. (1971) J Amer Oil Chem Soc 48:700-701 ).
- E5-desaturase activity has been described in Aquilegia vulgaris (Longman et al. (2000) Biochem Soc Trans 28:641- 643).
- no plants have been described which contain either trans-vaccenic acid (E1 1 -octadecenoic acid) or E10-octadecenoic acid.
- fatty acid ACP esters are desaturated by a soluble desaturase, predominantly at position 9, and
- membrane lipids especially phosphatidyl cholins, are preferentially further desaturated at positions 6, 12 and 15 by membrane- bound desaturases.
- conjugated fatty acids are produced by the activity of a conjugase (Crombie et al. (1984) J Chem Soc Chem Commun 15:953-955; Crombie et al. (1985) J Chem Soc Perkin Trans 1 :2425-2434; Fritsche et al. (1999) FEBS Letters 462: 249- 253; Cahoon et al. (2001 ) J Biol Chem 276:2637-2643; Qiu et al. (2001 ) Plant Physiol 125:847-855).
- conjugated fatty acids such as calendulic acid, eleostearic acid or punicic acid proceeds via the desaturation of oleic acid to linoleic acid by a D12-desaturase and a further desaturation in conjunction with a rearrangement of the Z9- or Z12-double bond to the conjutrienic fatty acid by a specific conjutriene-forming desaturase (conjugase).
- conjugated fatty acids such as calendulic acid, eleostearic acid or punicic acid proceeds via the desaturation of oleic acid to linoleic acid by a D12-desaturase and a further desaturation in conjunction with a rearrangement of the Z9- or Z12-double bond to the conjutrienic fatty acid by a specific conjutriene-forming desaturase (conjugase).
- conjugated linoleic acid by the enzymatic activity of conjugase.
- Liu et al. describe an E11- desaturase from the pheromone gland of a moth species ("light brown apple moth"), which is likely to play a role in pheromone biosynthesis (Liu WT et al. (2002) Proc Natl Acad Sci USA 99(2):620-624.
- Knipple et al. compare various integral membrane desaturases from moths and flies which have been isolated from the pheromone glands of these insects.
- a fragment of an acyl-CoA desaturase (PgosVASQ) from Pectinophora gossypiella is described.
- the corresponding sequence has been deposited under the GeneBank Ace. No.: AF482921. Neither the complete sequence nor the specific activity of the desaturase are described. It was named merely on the basis of homologies with other desaturases.
- a first subject matter of the invention relates to processes for the production of triglycerides comprising unsaturated fatty acids by the recombinant expression of at least one fatty acid desaturase from insects of the order Lepidoptera.
- the process for the production of triglycerides comprising unsaturated fatty acids comprises the recombinant expression of at least one fatty acid desaturase from insects of the order Lepidoptera in an organism selected from the group of the plant organisms, yeasts, fungi and algae.
- fatty acid desaturases are employed which are capable of generating a double bond at position C8, C9, C10, C1 1 or C12 in fatty acids, fatty acid CoA esters or other fatty acid derivatives.
- fatty acid desaturases which are capable of specifically generating a cis or trans double bond in fatty acids, fatty acid CoA esters or other fatty acid derivatives with a fatty acid chain length of 16 or 18 C atoms.
- Very especially preferred are fatty acid desaturases with at least 65% homology with one of the fatty acid desaturases described by SEQ ID NO: 2, 4, 6, 8, 10, 12, 14 or 22.
- the process is employed for producing conjugated linoleic acid as the unsaturated fatty acid.
- triglycerides prepared by the process according to the invention, and their use for preparing foodstuffs, feedstuffs, cosmetics or fine chemicals.
- the advantage of the process according to the invention is, in particular, the possibility of the direct production of CLA-containing triglycerides, starting from organisms, preferably plants, yeasts, fungi or algae, with a high oil content, such as, for example, oilseed rape or sunflower.
- organisms preferably plants, yeasts, fungi or algae
- a high oil content such as, for example, oilseed rape or sunflower.
- eukaryotic enzymes from insects of the order Lepidoptera makes possible good expression without the toxic effects frequently linked to prokaryotic proteins.
- Fatty acid desaturases refers to enzymes which are capable of introducing a double bond into fatty acids or their derivatives, such as, for example, preferably fatty acid CoA esters. If appropriate, cofactors such as NADPH, NADH or else oxygen may additionally be necessary for this purpose. Preferred in this context are those desaturases which are capable of utilizing those acyl-CoA fatty acids as substrate whose fatty acid has a chain length of 14, 16, 18 or 20 C atoms, preferably 18 C atoms.
- fatty acid desaturases encompasses those enzymes which are capable of generating a double bond at position C8, C9, C10, C1 1 or C12 in fatty acids or their derivatives, such as, for example, preferably fatty acid CoA esters.
- those desaturases which lead to specific structural isomers, that is to say specifically to cis or trans double bonds. Specifically in this context is understood as meaning that the structural isomer in question is formed in an amount of at least 60%, preferably at least 80%, very especially preferably at least 90%, most preferably at least 95%.
- desaturases which generate, in fatty acids or their derivatives, such as, for example, preferably fatty acid CoA esters, a double bond as is found in a CLA isomer.
- Preferred essential characteristic of a fatty acid desaturase from lepidopterans refers to enzymes with at least one of the following characteristics:
- substrate specificity refers to the characteristic of a fatty acid desaturase, of converting substrates of the stated chain length more rapidly than substrates of a different chain length.
- the conversion rate of the preferred substrate is increased by at least 50%, preferably by at least 100%, very especially preferably by at least 200%, most preferably by at leat 500% in comparison with the substrates which are not preferred.
- Preferred is at least in each case one of characteristics i) and ii).
- fatty acid desaturases encompasses enzymes which are capable of introducing an isolated double bond, but also conjugases which, starting from one double bond in a substrate, are capable of generating a conjugated double bond system. In this context, it is preferably the first double bond which is moved.
- these enzymes can be referred to as (E10,Z12)-conjugases.
- These enzymes can also be referred to as E10-desaturases.
- the essential characteristic of the very especially preferred E10-desaturates is the introduction of a trans double bond at position C-10 of a fatty acid or of a fatty acid CoA ester, where the fatty acid has a chain length of 18 C atoms.
- conjugases are those which are identical to each other.
- these enzymes can be referred to as (Z9,E1 1 )-conjugases.
- These enzymes can also be referred to as E1 1 -desaturases.
- the essential characteristic of the very especially preferred E1 1 -desaturases is the introduction of a trans double bond at position C1 1 of a fatty acid or of a fatty acid CoA ester, where the fatty acid has a chain length of 18 C atoms.
- E10-, E1 1 -, Z10- and Z11 -desaturases and Z1 1 -(E10,Z12)- conjugase, E11 -(E10,Z12)-conjugase, Z10-(Z9,E11 )-conjugase and E10-(Z9,E11 )- conjugase with a substrate specificity for fatty acids or fatty acid derivative such as fatty acid CoA esters with a fatty acid chain length of 18 C atoms.
- the fatty acid desaturases preferably originate from a Lepidoptera family selected from the group consisting of Acrolepiidae, Agaristidae, Arctiidae, Bombycidae, Carposinidae, Cochylidae, Cossidae, Eriocraniidae, Gelechiidae, Geometridae, Gracillariidae, Hepialidae, Ithomiidae, Lasiocampidae, Lycaenidae, Lymantriidae, Lyonetiidae, Nepticulidae, Noctuidae, Notodontidae, Nymphalidae, Oecophoridae, Papilionidae, Pieridae, Psychidae, Pterophoridae, Pyralidae, Saturniidae, Sesiidae, Sphingi
- E1 1 -desaturases are preferably isolated from organisms of the species Diaphania hyalinata, Diaphania nitidalis, Leucinodes orbonalis, Ostrinia nubilalis, Sesamia grisescens, Brachmia macroscopa, Paraargyresthia japonica, Mnesictena flavidalis, Telorta edentata, Epiplema moza, Argyresthia chamaecypariae, Bradina sp., Dichrocrocis punctiferalis, Cryptoblabes gnidiella, Palpita unionalis, Sceliodes cordalis, Anisodes sp., Caloptilia theivora,
- the E1 1 -desaturases, or the nucleic acid sequences encoding them, are especially preferably isolated from the pheromone glands of the above insects.
- An example which may be mentioned is the E1 1 -desaturase from the pheromone glands of the light brown apple moth (Epiphyas postvittana) (SEQ ID NO: 2), from Ostrinia nubilalis (SEQ ID NO:4) and from Ostrinia furnicalis (SEQ ID NO: 6).
- E11 -desaturase from Pectinophora gossypiella as shown in SEQ ID NO: 22.
- the E1 1 -desaturases from the abovementioned organisms accept the plant acyl-CoA fatty acid derivatives as substrate.
- desaturases are particularly advantageous in as far as it makes possible an E11 double bond.
- Said desaturases are preferably optimized with a view to being able preferably to convert C16 and/or C18 acyl-CoA substrates, if they are not already capable of doing so (such as, for example, the desaturase from Pectinophora gossypiella as shown in SEQ ID NO: 22).
- a further subject matter of the invention therefore relates to polypeptides with E11 -desaturase activity, the polypeptide preferentially converting C16 and/or C18 acyl-CoA fatty acids and encompassing at least one sequence selected from the group consisting of
- amino acid sequences with at least 65% homology with one of the amino acid sequences as shown in SEQ ID NO: 2, 4, 6 or 22, and
- amino acid sequences which encompass a fragment of at least 20 contiguous amino acid residues of a sequence as shown in SEQ ID NO: 2, 4, 6 or 22.
- polypeptide is especially preferably described by an amino acid sequence as shown in SEQ ID NO: 22.
- a further subject matter of the invention relates to nucleic acid molecules which encode said desaturases.
- the sequence is especially preferably as shown in SEQ ID NO: 21.
- E10-desaturases, or the nucleic acid sequences encoding them are preferably isolated from organisms of the species Dichrocrocis chlorophanta, Dichrocrocis punctiferalis, Bombyx mandarina, Bombyx mori, Coloradia velda, Hemileuca eglanterina, Hemileuca electra electra, Hemileuca electra mojavensis, Hemileuca nuttalli or Notarcha derogata.
- the E10-desaturases, or the nucleic acid sequences encoding them are especially preferably isolated from the pheromone glands of the abovementioned insects.
- E9-desaturases, or the nucleic acid sequences encoding them are preferably isolated from organisms of the species Epiplema plaqifera, Phyllonorycter coryli, Phyllonorycter harrisella, Phyllonorycter sylvella, Gelechiinae, Bryotropha sp., Bryotropha terrella, Gelechia betulae, Adoxophyes orana, Exartema appendiceum, Zeiraphera canadensis, Loxostege neobliteralis, Ostrinia nubilalis, Dioryctria clarioralis, Dioryctria merkeli, Dioryctria resinosella, Spodoptera exigua, Spodoptera triturata oder Polia grandis.
- the E9-desaturases, or the nucleic acid sequences encoding them are especially preferably isolated from the pherom
- E8-desaturases or the nucleic acid sequences encoding them, are preferably isolated from organisms of the species Phyllonorycter saportella, Phyllonorycter sp. or Dichrocrocis punctiferalis.
- the E8-desaturases, or the nucleic acid sequences encoding them are especially preferably isolated from the pheromone glands of the abovementioned insects.
- Z11 -desaturases as can be employed advantageously for producing Z1 1-octadecenoic acid have been described for Bombyx mori (Ando et al. (1988) Agric Biol Chem. 52:473-478), Trichoplusia ni and Helicoverpa zea (Knipple et al. (1998) Proc Nat Acad Sci USA 95:15287-15292).
- Z11 -desaturases can preferably be isolated from Manduca sexta, Diatraea grandiosella, Earias insulana, Earias vittella, Plutella xylostella, Bombyx mori or Diaphania nitidalis. Examples which may be mentioned are the desaturases from Helicoverpa zea (SEQ ID NO: 8), Trichoplusia ni (SEQ ID NO: 10) and Argyrotaenia velutinana (SEQ ID NO: 12). Z11 -desaturases, or the nucleic acid sequences encoding them, are especially preferably isolated from pheromone glands of the abovementioned insects.
- Z10-desaturases are preferably isolated from organisms of the species Ctenopseustis filicis, Pseudexentera spoliana, Hemileuca eglanterina, Hemileuca electra electra, Hemileuca electra mojavensis, Hemileuca nuttalli, Eurhodope advenella, Mamestra configurata or Dichrocrocis punctiferalis, especially preferably from the pheromone glands of the abovementioned insects.
- An example which may be mentioned is the desaturase from Planototrix octo (SEQ ID NO: 14).
- (E10,Z12)-conjugases, or the nucleic acid sequences encoding them are preferably isolated from Bombyx mori, Phyllonorycter crataegella, Amorbia cuneana, Notocelia incarnatana, Notocelia uddmanniana, Bombyx mandarina, Coloradia velda, Hemileuca eglanterina, Hemileuca electra electra, Hemileuca electra mojavensis, Hemileuca nuttalli, Notarcha derogata, Rondotia menciana, Amphion floridensis, Hyles gallii, Hyloicus pinastri, Manduca sexta, Sphinx drupiferarum, Earias insulana, Nola confusalis or Notarcha basipunctalis. (E10,Z12)-conjugases or the nucleic acid sequences encoding them, are especially preferably isolated from
- (Z9.E1 1 )-conjugases are preferably isolated from Diatraea saccharalis , Xyrosaris lichneuta, Dioryctria abietella, Stenoma cecropia, Phalonidia manniana, Pselnophorus vilis, Dioryctria abietella; Dioryctria rubella, Myelopsis tetricella, Jodis lactearia, Scopula personata, Spodoptera descoinsi, Spodoptera eridania, Spodoptera latifascia, Spodoptera littoralis or Spodoptera litura.
- (Z9.E11)-conjugases are especially preferably isolated from the pheromone glands of the abovementioned insects.
- palmitelaidic acid (9E-hexadecenoic acid) is produced via trans-desaturation at position C9, for example by an E9-desaturase. Palmitelaidic acid can subsequently be elongated via the enzymatic activity of an elongase to give trans-vaccenic acid (scheme 4).
- Trans-vaccenic acid can then be converted by a D9-desaturase to give the (9Z,1 1 E)-CLA isomer. It has been demonstrated for mammals and humans that trans-vaccenic acid is converted into CLA by the enzymatic activity of an endogenous D9-desaturase (WO 99/20123; Santora JE et al. (2000) J Nutr 130:208-215; Adlof RO et al. (2000) Lipids 35: 131-135). Likewise, it has been demonstrated that insect cells which express a E11 -desaturase are capable of converting the resulting E1 1 -fatty acid starting material into a Z9,E11 -fatty acid
- plant D9- desaturases are capable of catalyzing the conversion of trans-vaccenic acid into the (Z9,E1 1 )-CLA isomer.
- this conversion can be further increased by additional expression of a Z9-desaturase.
- cytosolically active Z9-desaturases such as, for example, the yeast Z9-desaturase.
- E10-octadecenoic acid is initially formed by trans-desaturation at position C10 (scheme 3).
- E8- hexadecenoic acid can be produced starting from palmitic acid via trans- desaturation at position C8.
- the E8-hexadecenoic acid can subsequently be illustrated via the enzymatic activity of an elongase to give E10-octadecenoic acid (scheme 4).
- This fatty acid will be converted by the activity of a D 12-desaturase to give the (E10,Z12)-CLA isomer.
- This reaction is also catalyzed by plant D12- desaturases. In a particularly preferred embodiment, this conversion rate can be increased further by additional expression of a Z12-desaturase.
- Corresponding (E10,Z12)-conjugases from lepidopterans may also be employed. These conjugases convert for example Z11-octadecenoic acid (cis-vaccenic acid), E1 1-octadecenoic acid (trans-vaccenic acid) or Z10-otadecenoic acid into (E10,Z12)-CLA. To this end, stearic acid is first converted into Z1 1 -octadecenoic acid, as a result of the effect of a Z1 1 -desaturase, into trans-vaccenic acid as described above or into Z10-octadecenoic acid by a Z10-desaturase.
- (Z9,E11 )-conjugases from lepidopterans can furthermore also be combined advantageously with (Z11 )-, (Z10)- or (E10)-desaturases.
- these desaturases produce Z11 -octadecenoic acid (cis-vaccenic acid), Z10- octadecenoic acid or E10-octadecenoic acid, which are subsequently converted by a (Z9/E11 )-conjugase to give (Z9.E1 1 )-CLA.
- the CLA fatty acids thus prepared, or their derivatives such as CoA fatty acid esters, are stored in the membrane lipids and triacyl glycerides.
- the desirable enzyme activities have been localized in insects of the order lepidopterans, in particular in the abovementioned insect species.
- the assay systems provided within the present invention were used for this purpose (Examples 2, 3 and 4).
- the enzymes encoding these activities, or the nucleic acid sequences encoding them, can be isolated from the organisms in question in the manner with which the skilled worker is familiar or deduced by mutagenesis from corresponding known sequences.
- Finding a protein sequence or a corresponding cDNA sequence to an enzymatic activity, functionality or phenotype is a traditional task in biochemistry and molecular biology.
- the skilled worker is familiar with a variety of processes for solving this problem.
- these methods are based on the assays provided within the present invention for determining the desaturase or conjugase activity (see, inter alia, Example 3).
- the specific activity of a desaturase/conjugase in question is determined via analyzing the fatty acid pattern, for example by gas chromatography as described in Examples 2, 3 and 4.
- expression cloning may be employed by way of method. This method has frequently been employed for isolating, starting from a particular enzymatic activity, a particular functionality or a particular phenotype, the gene responsible therefor or the cDNA corresponding to this gene (Dalboge H (1997) FEMS Microbiology Reviews 21 (1 ):29-42, Simonsen H and Lodish HF (1994) Trends Pharmacol Sci 15(12):437- 441 ). The traditional method of expression cloning has been described on a number of occasions, for example for membrane proteins, secreted factors and transmembrane channels (Masu Y et al.
- an expression library can be generated starting from an organism, from cells or tissue which are capable of generating a desaturase or conjugase activity.
- mRNA or, preferably, poly(A)-mRNA is first isolated from said organism, cell or tissue in a manner with which the skilled worker is familiar, and cDNA is prepared on the basis of what has been isolated (Gubler U, Hoffman BJ (1983) Gene 25:263-269).
- the skilled worker is familiar with a variety of systems for isolating mRNA or poly(A)- mRNA and they are commercially available.
- the synthesis can be carried out using the "Quick Prep Micro mRNA Purification Kit" (Amersham Pharmacia Biotech).
- the first-strand cDNA synthesis is preferably carried out with an oligo(dT) primer using a reverse transcriptase (Borson ND et al. (1992) PCR Methods Appl 2:144-148; Chenchik A et al. (1994) CLONTECHniques 9(1 ):9-12).
- a reverse transcriptase Bosset ND et al. (1992) PCR Methods Appl 2:144-148; Chenchik A et al. (1994) CLONTECHniques 9(1 ):9-12.
- a variety of systems which make possible the generation of full-length cDNAs are known and commercially available. An example which may be mentioned is the "SMARTTM cDNA Library Construction Kit" (Clontech, Cat.#K1051 -1 ).
- SMART Switch Mechanism At the 5' end of RNA Templates
- cDNA libraries Herrler M (2000) J Mol Med 78(7):B23.
- Specific oligonucleotides and the method which is known as long-distance PCR are employed. The method is described in Example 4.
- Adaptors with single-stranded overhangs can be ligated to the double-stranded cDNAs; these adaptors make possible cloning for example in an expression vector which has been cleaved with restriction enzymes and has compatible cohesive ends.
- cloning is directed so that the direction of reading is fixed and any promoter which may be present generates sense RNA starting from the cDNA insertion.
- compatible Sfil (A) and Sfil (B) overhangs are used for directed cloning into an Sfil (recognition sequence GGCCNNNNINGGCC)- cleaved vector.
- cDNA molecule is cloned into a vector molecule, so that eventually a multiplicity of vectors which are based on the same basic vector and which differ with regard to the integrated cDNA are present and form the expression libirary.
- This expression library also contains vectors which are capable of expressing a desaturase or conjugase transgene. Suitable expression vectors are, in principle, all those which are capable of recombinantly expressing, in a transformed organism, desaturases or conjugases in active form.
- Examples which may be mentioned are the lambda TriplEX2 vector (after excision pTriplEX2 vector; manufacturer: Clontech) for the recombinant expression in E.coli or the vector pYES2 (manufacturer: Invitrogen) for the recombinant expression in the yeast S.cerevisiae (see Example 4).
- a normalization can be carried out in order to compensate for differences in the expression level of individual genes, so that the cDNA to each gene which is expressed is represented in the expression library with a similar copy number, independently of the actual expression level.
- a variety of systems have been described for the generation of poly(A)-mRNA, cDNA and standardized cDNA (US 5,482,845) (Soares MB et al. (1994) Proc Natl Acad Sci USA 91 :9228-9232; Carninci P et al. (2000) Genome Res 10:1617-1630; Bonaldo MF et al. (1996) Genome Res 6:791 -806).
- a subtractive expression library may also be established.
- the cDNAs of an organism, of cells or of tissue with a desaturase or conjugase are compared with the cDNAs of an organism, of cells or of tissue without this activity, if possible of the same genus and species.
- the skilled worker is familiar with methods for the targeted isolation of cDNAs which are only expressed in the biological material with desaturase or conjugase activity. Such methods and systems are described and commercially available.
- the cDNAs in the expression library can be expressed recombinantly for example in prokaryotic or eukaryotic cells which are subsequently subjected to an assay for the desaturase or conjugase protein, for example an assay for a desaturase or conjugase activity.
- the expression library is preferably transformed into an organism.
- individual cells of the said organism are transformed in such a way that each cell, or each organism which is regenerated starting from this cell, is transformed with one type of vector molecule only.
- all those organisms, or cells derived from them, which are capable of recombinantly expressing an active desaturase or conjugase are suitable for transformation. These organisms may be prokaryotic and eukaryotic. Preferred are all plants, cells derived from them, but also other photosynthetic organisms such as, for example, algae.
- Preferred organisms are eukaryotic organisms, very especially preferably eukaryotic organisms which are capable of synthesizing fatty acids or acyl- CoA fatty acids.
- the expression vectors used for the transformation contain a selection marker, for example a resistance antibiotic or an amino acid synthesis gene for selection for amino acid deficiency, which makes possible the selection of successfully transformed cells. Further selection methods are described hereinbelow.
- expression cloning can be carried out in yeast.
- yeast expression system from Invitrogen which is based on the vector pYES2.
- pYES2 is a high-copy episomal vector for inducible expression of recombinant proteins in S. cerevisiae.
- Transformed yeast strains are selected on the basis of uracil deficiency (pYES2 contains the ura3 gene).
- the desaturase activity can be detected by culturing a transformed organism or cells derived therefrom, digesting it/them in a suitable buffer or solvent, bringing the digest into contact with fatty acids or acyl-CoA fatty acids and, if appropriate, with a cofactor such as NADH or NADPH or oxygen, and detecting the resulting desaturated fatty acids or acyl-CoA fatty acids.
- the fatty acids or acyl-CoA fatty acids can preferably originate from the transformed organism itself if the organism or the cell derived from it is itself capable of synthesizing fatty acids or acyl-CoA fatty acids. If not, however, it is also possible to add fatty acids or acyl-CoA fatty acids.
- the fatty acid or acyl-CoA fatty acid which has been modified by the desaturase or conjugase can be detected via customary methods with which the skilled work is familiar, if appropriate after extraction from the incubation mixture, for example with a solvent such as ethyl acetate.
- Separation methods such as high-performance liquid chromatography (HPLC), gas chromatography (GC), thin-layer chromatogaphy (TLC) and detection methods such as mass spectroscopy (MS or MALDI), UV spectroscopy or autoradiography may be employed for this purpose.
- the detection is carried out using gas chromatography as described in Examples 3, 4 and 5.
- the transformed organisms, or cells derived from them, which are capable of recombinantly expressing a desaturase or conjugase can be isolated for example by dividing the total number of cells into subgroups, culturing these subgroups, if appropriate separately, and measuring the desaturase or conjugase activity of the individual subgroups.
- the subgroup which contains a cell type which recombinantly expresses a desaturase or conjugase protein in functionally active form has an increased desaturase or conjugase activity.
- This subgroup is subdivided further and the procedure is repeated until the result is a monoclonal culture, i.e. a culture which contains only one vector with a specific cDNA which encodes a desaturase or conjugase.
- the vector which contains the nucleic acid encoding the desaturase or conjugase can be recovered from the transformed organism or cell. This can be done for example by means of polymerase chain reaction (PCR). To this end, oligonucleotide primers which are complementary to vector sequences which flank the desaturase or conjugase cDNA insert are used. A knowledge of the desaturase or conjugase nucleic acid sequence is not required in this context.
- the vector if not integrated into the host genome, can be recovered from the cells, transformed into E.coli, propagated and sequenced in order to obtain the nucleic acid sequence encoding the desaturase or conjugase.
- the desaturase or conjugase nucleic acid sequence can also be isolated from the isolated vector by means of PCR, without knowing its sequence order.
- linkers which make possible directed cloning, may be added to the amplicon after the PCR reactions.
- cloning can also be effected by means of blunt-end ligation or T-overhang ligation in a manner with which the skilled worker is familiar.
- the desaturase or conjugase cDNA which has been amplified selectively by means of PCR may thus also be cloned directly into a vector suitable for generating a transgenic organism which expresses a desaturase or conjugase, without previous sequence elucidation.
- This cloning procedure can be effected for example as a blunt-end cloning procedure using techniques with which the skilled worker is familiar. Customary recombination and cloning techniques as cited above are used for this purpose.
- the above-described method of expression cloning can especially preferably be carried out in the yeast Saccharomyces cerevisiae. To this end, it is also possible to use systems in which the cDNAs to be expressed recombinantly are integrated, by means of homologous recombination, into an integration platform which has been generated (Lagarde D et al. (2000) Applied and Environmental Microbiology 66(1 ): 64- 72).
- an oligo(dT)-primed cDNA library is constructed as described above and cloned into a high-copy expression plasmid with a T3, T7 or SP6 promoter.
- This plasmid library is then transformed into E.coli.
- approximately 50 to 100 independent tranformants are cultured on an agar plate with the corresponding selection antibiotic to a colony size of approx. 1 mm, collected and pooled. Plasmid DNA is isolated from part of this bacterial pool.
- This plasmid DNA which is used as template, is transcribed directly in a reticulocyte system and translated.
- the nucleic acid encoding the desaturase or conjugase can be amplified by PCR from the vectors present in this preparation and - if appropriate without knowledge and analysis of the sequence - used as described above for generating an organism which recombinantly expresses a desaturase or conjugase.
- wheatgerm extract may also be used for the combined transcription/translation procedure (for example using the TNTTM Wheat Germ Extract System from Clontech).
- the cDNAs can be cloned into a retroviral vector.
- Retroviral expression vectors and expression systems are described (Kitamura T, International Journal of Hematology 1998, 67:351 -359) and commercially available (for example from Clontech; New Retroviral & ClonCapture Expression Libraries; CLONTECHniques October 1998, XIII(4):22-23).
- Transfection is initially performed in a packaging cell line (for example EcoPackTM-293 or RetroPackTM PT67 Cell Line from Clontech). Using the viruses generated in this manner, the target cell line in question can be transfected and selected for the desired activity.
- the inserts can be obtained and analyzed, for example by PCR. Furthermore, they can be cloned directly into a suitable expression vector, even without previously subjecting them to sequence analysis, and this expression vector can then be used for generating an organism which recombinantly expresses desaturase or conjugase.
- E10- or E11 -desaturases can be obtained by modifying known cis-desaturases via mutagenesis in such a way that they are specific for desaturation in the trans-position.
- mutagenesis for example the following nucleic acid sequences encoding cis- desaturases can act as starting sequences and be subjected to mutagenesis:
- E1 1 -desaturases can be modified by mutagenesis in such a way that longer- chain fatty acids can be converted more efficiently, or at all.
- Nucleic acid sequences encoding desaturases/conjugases for use in the method according to the invention can also be isolated by means of polymerase chain reaction using suitable degenerate oligonucleotide primers from cDNA preparations or libraries of the respective abovementioned Lepidoptera species. Those which are preferably employed are the oligonucleotide primer pair which is described by SEQ ID NO: 15 and 16 or the oligonucleotide primer pair which is described by SEQ ID NO: 17 and 18.
- nucleic acid sequence of the fatty acid desaturase from lepidopterans which is employed in the process according to the invention preferably comprises
- the protein sequence of the fatty acid desaturase from lepidopterans which is used in the process according to the invention, preferably has at least 65%, preferably at least 70%, especially preferably at least 80%, very especially preferably at least 90%, homology with one of the fatty acid desaturases described by SEQ ID NO: 2, 4, 6, 8, 10, 12 or 14 and - optionally and preferably - has at least one of the preferred essential characteristics of a desaturase or conjugase.
- These proteins can also encompass natural or artificial mutations of one of the abovementioned desaturase nucleic acid sequences and their homologs from other animal or plant genera and species.
- Mutations encompass substitutions, additions, deletions, inversions or insertions of one or more nucleotide residues. Where insertions, deletions or substitutions, such as, for example, transitions and transversions, are suitable, techniques which are known per se, such as in vitro mutagenesis, primer repair, restriction or ligation can be used. Complementary ends of the fragments can be provided for ligation by manipulations such as, for example restriction, chewing-back or filling up overhangs for blunt ends. Analogous results can also be obtained using the polymerase chain reaction (PCR) using specific oligonucleotide primers.
- PCR polymerase chain reaction
- the nucleic acid sequence encoding the fatty acid desaturase from lepidoterans which is employed in the process according to the invention preferably has at least 65%, preferably at least 70%, especially preferably at least 80%, very especially preferably at least 90% homology with one of the nucleic acid sequences described by SEQ ID NO: 1 , 3, 5, 7, 9, 11 or 13 and which - optionally and preferably - encodes a protein which has at least one of the preferred essential characteristics of a desaturase or conjugase.
- Gap Weight 12 Length Weight: 4
- nucleic acid sequence encoding the fatty acid desaturase from lepidopterans which is employed in the method according to the invention preferably hybridizes under standard conditions with one of the abovementioned nucleic acid sequences encoding desaturases, preferably with the sequence as shown in SEQ ID NO: 1 , 3, 5, 7, 9, 11 or 13.
- Standard hybridization conditions is to be understood in the broad sense and refers to stringent or else less stringent hybridization conditions. Such hybridization conditions are described, inter alia, by Sambrook J, Fritsch EF, Maniatis T et al., in Molecular Cloning (A Laboratory Manual), 2 nd edition, Cold Spring Harbor Laboratory Press, 1989, pages 9.31 -9.57) or in Current Protocols in Molecular Biology, John Wiley
- the conditions during the wash step can be selected from the range of conditions delimited by those with low stringency
- the temperature during the wash step can be raised from low-stringency conditions at room temperature, approximately 22°C, to higher-stringency conditions at approximately 65°C.
- the two parameters, salt concentration and temperature can be varied simultaneously or else one of the two parameters can be kept constant while only the other one is varied.
- Denaturing agents such as, for example, formamide or
- SDS can also be employed during the hybridization reaction.
- the hybridization reaction is preferably carried out at 42°C.
- nucleic acid sequence refers to, for example, a genomic or a complementary DNA (cDNA) sequence or an RNA sequence, and semi-synthetic or fully synthetic analogs thereof. These sequences can exist in linear or circular form, extrachromosomally or integrated into the genome.
- the nucleotide sequences of the expression cassettes or nucleic acids according to the invention can be generated synthetically or obtained naturally or comprise a mixture of synthetic and natural DNA constituents, and consist of various heterologous gene segments of various organisms.
- artificial nucleic acid sequences are suitable as long as they have the desired essential characteristics. For example, synthetic nucleotide sequences with codons which are preferred by plants to be transformed can be generated.
- codons which are preferred by plants can be determined in the customary manner on the basis of the codon usage from codons with the highest protein frequency.
- coding nucleotide sequences which have been obtained by backtranslation of a polypeptide sequence in accordance with the host-plant-specific codon usage.
- nucleotide sequences can be synthesized chemically in the manner known per se from the nucleotide units, such as, for example, by fragment condensation of individual, overlapping complementary nucleic acid units of the double helix.
- Oligonucleotides can be synthesized chemically for example in a manner known per se by the phosphoamidite method (Voet, Voet, 2 nd edition, Wiley Press New York, pages 896-897).
- various DNA fragments can be manipulated in such a way that a nucleotide sequence with the correct direction of reading and the correct reading frame is obtained.
- Adapters or linkers can be added to the fragments in order to link the nucleic acid fragments with each other.
- the addition of synthetic oligonucleotides and the filling up of gaps with the aid of the Klenow fragment of the DNA polymerase, ligation reactions and general cloning methods are described by Sambrook et al. (1989). Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press.
- transgenicTrecombinant refers to all those constructions which have come about by recombinant methods, or to their use, in which either
- a genetic control sequence for example a promoter, linked operably to the nucleic acid sequence encoding a desaturase, or
- the term natural genetic environment refers to the natural chromosomal locus in the organism of origin or to the presence in a genomic library.
- the natural genetic environment of the nucleic acid sequence is preferably retained at least in part.
- the environment flanks the nucleic acid sequence at least unilaterally and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, very especially preferably at least 5000 bp.
- non-natural, synthetic processes such as, for example, mutagenization.
- Recombinant expression refers to the use of a recombinant expression cassette for expressing a nucleic acid sequence.
- the invention furthermore relates to recombinant expression cassettes which comprise a desaturase-encoding nucleic acid sequence, and vectors encompassing these expression cassettes.
- a desaturase-encoding nucleic acid molecule is preferably in operable linkage with at least one genetic control element (for example a promoter) which ensures the recombinant expression (transcription and/or translation) of said desaturase in an organism, preferably in plants, plant organisms, algae, yeasts or fungi.
- a genetic control element for example a promoter
- plant-specific genetic control elements for example promoters
- the desaturase can also be expressed in other organisms or in vitro.
- preferred prokaryotic or eukaryotic genetic control elements are all those which allow for expression in the organism chosen in each case for the production.
- the invention furthermore therefore relates to recombinant expression cassettes comprising at least one nucleic acid sequence encoding a fatty acid desaturase from insects of the order Lepidoptera under the control of a promoter which is functional in plants, plant organisms, algae, yeasts or fungi.
- the nucleic acid sequence which is present in the expression cassettes encodes a polypeptide which encompasses at least one sequence selected from the group consisting of
- amino acid sequences as shown in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14 or 22 and b) amino acid sequences with at least 65% homology with one of the amino acid sequences as shown in SEQ ID NO: 2, 4, 6, 8, 10, 12, 14 or 22, and
- amino acid sequences which encopass a fragment of at least 20 contiguous amino acid sequences of a sequence as shown in SEQ ID NO: 2, 4, 6, 8, 10, 12,
- the fatty acid desaturase is especially preferably described in this context by an amino acid sequence as shown in SEQ ID NO: 22.
- the invention furthermore relates to recombinant expression vectors which comprise at least one of the expression cassettes according to the invention and to transgenic organisms which comprise at least one of the recombinant expression cassettes according to the invention or one of the recombinant expression vectors according to the invention.
- the transgenic organism is a plant organism, especially preferably selected from the plants used for oil production such as, for example, sunflower, sesame, safflower, olive tree, soya, linseed, peanut, castor-oil plant, oil palm, maize, wheat, cocoa bush and nut species.
- Operable linkage is understood as meaning, for example, the sequential arrangement of a promoter with the desaturase nucleic acid sequence to be expressed and, if appropriate, further regulatory elements such as, for example, a terminator in such a way that each of the regulatory elements can fulfil its function when the nucleic acid sequence is expressed recombinantly.
- Direct linkage in the chemical sense is not necessarily required for this purpose.
- Genetic control sequences such as, for example, enhancer sequences can also exert their function on the target sequence from positions which are further removed or indeed from other DNA molecules.
- Preferred arrangements are those in which the nucleic acid sequence to be expressed recombinantly is positioned behind the sequence acting as promoter so that the two sequences are linked covalently to each other.
- the distance between the promoter sequence and the nucleic acid sequence to be expressed recombinantly is preferably less than 200 base pairs, particularly preferably less than 100 base pairs, very particularly preferably less than 50 base pairs.
- Operable linkage and a transgenic expression cassette can both be produced by means of conventional recombination and cloning techniques as they are described, for example, in Maniatis T, Fritsch EF and Sambrook J (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor (NY), in Silhavy TJ, Berman ML und Enquist LW (1984) Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor (NY), in Ausubel FM et al. (1987) Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley
- the recombinant expression cassette composed of a promoter linked to a nucleic acid sequence to be expressed can be in a vector-integrated form and can be inserted into a plant genome, for example by transformation.
- transgenic expression cassette is also understood as meaning those constructs where the nucleic acid sequence encoding a desaturase is placed behind an endogenous promoter in such a way that the latter controls the expression of the desaturase.
- the fusion of endogenous promoter and desaturase nucleic acid sequence, which is brought about by the insertion, is a recombinant expression cassette for the purposes of the invention.
- Plant-specific promoters are understood as meaning any promoter which is capable of governing the expression of genes, in particular foreign genes, in plants or plant parts, plant cells, plant tissues or plant cultures.
- expression may be, for example, constitutive, inducible or development-dependent. The following are preferred:
- Preferred vectors are those which make possible a constitutive expression in plants (Benfey et al. (1989) EMBO J.8, 2195-2002).
- “Constitutive” promoter refers to those promoters which ensure expression in a large number of, preferably all, tissues over a substantial period of plant development, preferably at all times during plant development.
- a plant promoter or promoter originating from a plant virus is especially preferably used.
- the promoter of the CaMV (cauliflower mosaic virus) 35S transcript (Franck et al. (1980) Cell 21 :285-294; Odell et al. (1985) Nature 313:810-812; Shewmaker et al.
- X03677 the promoter of the nopalin synthase from Agrobacterium, the TR dual promoter, the OCS (octopine synthase) promoter from Agrobacterium, the ubiquitin promoter (Holtorf S et al. (1995) Plant Mol Biol 29:637-649), the ubiquitin 1 promoter (Christensen et al. (1992) Plant Mol Biol 18:675-689; Bruce et al.
- promoters with specificities for the anthers, ovaries, flowers, leaves, stems, roots and seeds.
- Seed-specific promoters such as, for example, the phaseolin promoter (US 5,504,200; Bustos MM et al.
- seed-specific promoters are those of the gene encoding high-molecular weight glutenin (HMWG), gliadin, branching enyzme, ADP glucose pyrophosphatase
- Promoters which are furthermore preferred are those which permit a seed-specific expression in monocots such as maize, barley, wheat, rye, rice and the like.
- the promoter of the Ipt2 or Ipt1 gene (WO 95/15389, WO 95/23230) or the promoters described in WO 99/16890 (promoters of the hordein gene, the glutelin gene, the oryzin gene, the prolamin gene, the gliadin gene, the glutelin gene, the zein gene, the casirin gene or the secalin gene) can advantageously be employed.
- Tuber-, storage-root- or root-specific promoters such as, for example, the class I patatin promoter (B33) and the promoter of the cathepsin D inhibitor from potato.
- Leaf-specific promoters such as the promoter of the potato cytosolic FBPase (WO 97/05900), the SSU promoter (small subunit) of Rubisco (ribulose-1 ,5-bisphosphate carboxylase) or the potato ST-LSI promoter (Stockhaus et al. (1989) EMBO J 8:2445-2451 ).
- Flower-specific promoters such as, for example, the phytoene synthase promoter (WO 92/16635) or the promoter of the P-rr gene (WO 98/22593).
- Anther-specific promoters such as the 5126 promoter (US 5,689,049, US 5,689,051 ), the glob-l promoter and the g-zein promoter.
- the recombinant expression cassettes may also contain a chemically inducible promoter (review article: Gatz et al. (1997) Annu Rev Plant Physiol Plant Mol Biol 48:89-108), by means of which the expression of the exogenous gene in the plant can be controlled at a particular point in time.
- a chemically inducible promoter such as, for example, the PRP1 promoter (Ward et al. (1993) Plant Mol Biol 22:361 -366), a salicylic acid-inducible promoter (WO 95/19443), a benzenesulfonamide- inducible promoter (EP 0 388 186), a tetracyclin-inducible promoter (Gatz et al.
- promoters which are preferred are those which are induced by biotic or abiotic stress, such as, for example, the pathogen-inducible promoter of the PRP1 gene (Ward et al. (1993) Plant Mol Biol 22:361 -366), the heat-inducible hsp70 or hsp80 promoter from tomato (US 5,187,267), the low-temperature- inducible alpha-amylase promoter from potato (WO 96/12814), the light-inducible PPDK promoter or the wound-induced pinll promoter (EP375091 ).
- the pathogen-inducible promoter of the PRP1 gene Ward et al. (1993) Plant Mol Biol 22:361 -366
- the heat-inducible hsp70 or hsp80 promoter from tomato US 5,187,267
- the low-temperature- inducible alpha-amylase promoter from potato
- Pathogen-inducible promoters encompass the promoters of genes which are induced as the consequence of a pathogen attack, such as, for example, genes of PR proteins, SAR proteins, b-1 ,3-glucanase, chitinase and the like (for example Redolfi et al. (1983) Neth J Plant Pathol 89:245-254; Uknes, et al.
- wound-inducible promoters such as the promoter of the pinll gene (Ryan (1990) Ann Rev Phytopath 28:425-449; Duan et al. (1996) Nat
- suitable promoters are, for example, fruit-maturation-specific promoters, such as, for example, the fruit-maturation-specific promoter from tomato (WO
- Development-dependent promoters include some of the tissue-specific promoters since some tissues are formed naturally as the function of development.
- promoters which make possible expression in further plant tissues or in other organisms such as, for example, E.coli bacteria, may be linked operably with the nucleic acid sequence to be expressed.
- Suitable plant promoters are, in principle, all of the above-described promoters.
- nucleic acid sequences present in the recombinant expression cassettes or vectors according to the invention can be linked operably with further genetic control sequences besides a promoter.
- genetic control sequences is to be understood in the broad sense and refers to all those sequences which have an effect on the establishment or the function of the expression cassette according to the invention. Genetic control sequences modify, for example, transcription and translation in prokaryotic or eukaryotic organisms.
- the recombinant expression cassettes according to the invention preferably encompass the promoter with specificity for the embryonal epidermis and/or the flower 5'-upstream of the nucleic acid sequence to be expressed recombinantly in each case and, as additional genetic control sequence, a terminator sequence 3'-downstream, and, if appropriate, further customary regulatory elements, in each case operably linked with the nucleic acid sequence to be expressed recombinantly.
- Genetic control sequences also encompass further promoters, promoter elements or minimal promoters capable of modifying the expression-controlling properties.
- genetic control sequences can, for example, bring about tissue-specific expression which is additionally dependent on certain stress factors.
- Such elements are, for example, described for water stress, abscisic acid (Lam E and Chua NH, J Biol Chem 1991 ; 266(26): 17131 -17135) and thermal stress (Schoffl F et al. (1989) Mol Gen Genetics 217(2-3):246-53).
- control sequences are, for example, in the Gram-positive promoters amy and SP02, and in the yeast or fungal promoters ADC1 , MFa, AC, P-60, CYC1 , GAPDH, TEF, rp28, ADH.
- Genetic control sequences also further encompass the 5'-untranslated regions, introns or nonencoding 3'-region of genes, such as, for example, the actin-1 intron, or the Adh1 -S introns 1 , 2 and 6 (for general reference, see: The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, New York (1994)). It has been demonstrated that these may play a significant role in regulating gene expression. Thus, it has been demonstrated that 5'-untranslated sequences can enhance the transient expression of heterologous genes. Translation enhancers which may be mentioned by way of example are the tobacco mosaic virus 5' leader sequence (Gallie et al. (1987) Nucl Acids Res 15:8693-871 1 ) and the like. They may furthermore promote tissue specificity (Rouster J et al. (1998) Plant J 15:435-440).
- the recombinant expression cassette can advantageously contain one or more of what are known as enhancer sequences in operable linkage with the promoter, and these make possible an increased recombinant expression of the nucleic acid sequence. Additional advantageous sequences such as further regulatory elements or terminators may also be inserted at the 3' end of the nucleic acid sequences to be expressed recombinantly. One or more copies of the nucleic acid sequences to be expressed recombinanly may be present in the gene construct.
- Polyadenylation signals which are suitable as control sequences are plant polyadenylation signals, preferably those which correspond essentially to Agrobacterium tumefaciens T-DNA polyadenylation signals, in particular those of gene
- EMBO J 3:835 et seq. or functional equivalents thereof.
- particularly suitable terminator sequences are the OCS (octopine synthase) terminator and the NOS (nopaline synthase) terminator.
- Control sequences are furthermore understood as those which make possible homologous recombination or insertion into the genome of a host organism, or removal from the genome.
- Methods such as the cre/lox technology permit the tissue-specific, possibly inducible, removal of the recombinant expression cassette from the genome of the host organism (Sauer B (1998) Methods. 14(4):381 -92).
- certain flanking sequences are added to the target gene (lox sequences), and these make possible removal by means of ere recombinase at a later point in time.
- a recombinant expression cassette and the recombinant vectors derived from it may comprise further functional elements.
- the term functional element is to be understood in the broad sense and refers to all those elements which have an effect on the generation, replication or function of the recombinant expression cassettes, vectors or transgenic organisms according to the invention. Examples which may be mentioned, but not by way of limitation, are:
- Selection markers which confer resistance to a metabolism inhibitor such as 2- deoxyglucose-6-phosphate (WO 98/45456), antibiotics or biocides, preferably herbicides, such as, for example, kanamycin, G 418, bleomycin, hygromycin, or phosphinothricin and the like. Particularly preferred selection markers are those which confer resistance to herbicides.
- Reporter genes which encode readily quantifiable proteins and which allow the transformation efficiency or the expression site or time to be assessed via their color or enzyme activity.
- reporter proteins such as the "green fluorescent protein” (GFP) (Sheen et al.(1995) Plant Journal 8(5):777-784); Haseloff et al. (1997) Proc Natl Acad Sci USA 94(6):2122-2127; Reichel et al. (1996) Proc Natl Acad Sci USA 93(12):5888-5893; Tian et al.
- Replication origins which allow replication of the recombinant expression cassettes or vectors according to the invention in, for example, E.coli.
- ORI oil of DNA replication
- the pBR322 ori or the P15A ori (Sambrook et al.: Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989).
- a selectable marker which confers resistance to a biocide for example a herbicide
- a metabolism inhibitor such as 2-deoxyglucose-6-phosphate
- the recombinant expression cassette according to the invention can have the following structure:
- the recombinant expression cassette according to the invention preferably has the following structure:
- Cotransformation with more than one of the abovementioned examples a) or b) may be advantageous for the advantageous CLA biosynthesis processes according to the invention.
- transformation with one or more vectors, each of which contains a combination of the abovementioned recombinant expression cassettes, may be advantageous.
- said recombinant expression cassette may comprise a nucleic acid sequence whose recombinant expression brings about an increase in fatty acid biosynthesis (hereinbelow proOIL).
- This proOIL nucleic acid sequence which is additionally expressed recombinantly can be selected by way of example but not by limitation from among nucleic acids encoding acetyl-CoA carboxylase (ACCase), glycerol-3-phosphate acyltransferase (GPAT), lysophosphatidate acyltransferase (LPAT), diacylglycerol acyltransferase (DAGAT) and phospholipid:diacylglycerol- acyltransf erase (PDAT).
- ACCase acetyl-CoA carboxylase
- GPAT glycerol-3-phosphate acyltransferase
- LPAT lysophosphatidate acyltransferase
- DGAT diacyl
- the proOIL nucleic acid sequences also encompass those nucleic acids whose recombinant expression generates an antisense-RNA or a duplex RNA which also brings about an increase in the fatty acid production.
- Preferred examples encompass vectors comprising the following recombinant expression cassettes:
- the desaturase or proOIL nucleic acids or recombinant expression cassettes according to the invention can be cloned into suitable vectors which allow their propagation in, for example, E. coli.
- suitable cloning vectors are pBR332, pUC series, M13mp series and pACYC184, inter alia.
- binary vectors which are capable of replication both in E. coli and in agrobacteria.
- the desaturase or proOIL nucleic acids or recombinant expression cassettes according to the invention are preferably inserted into suitable transformation vectors.
- suitable vectors are described, inter alia, in "Methods in Plant Molecular Biology and Biotechnology” (CRC Press), chapter 6/7, p. 71-119 (1993). Transformation examples and transformation processes are described hereinbelow.
- the invention furthermore relates to transgenic organisms transformed with at least one recombinant expression cassette according to the invention or with a vector according to the invention, and to cells, cell cultures, tissues, parts - such as, for example, leaves, roots and the like in the case of plant organisms - or propagation material derived from such organisms.
- organism starting organisms or host organisms are understood as meaning prokaryotic or eukaryotic organisms such as, for example, microorganisms or plant organisms.
- Preferred microorganisms are bacteria, yeasts, algae or fungi.
- Preferred bacteria are bacteria from the genus Escherichia, Corynebacterium, Bacillus, Clostrridium, Proionibacterium, Butyrivibrio, Eubacterium, Lactobacillus, Erwinia,
- Agrobacterium Flavobacterium, Alcaligenes, Phaeodactylum, Colpidium, Mortierella, Entomophthora, Mucor, Crypthecodinium or cyanobacteria, for example of the genus Synechocystis.
- microorganisms which are capable of infecting plants and thus of transferring the constructs according to the invention.
- Preferred microorganisms are those of the genus Agrobacterium, in particular of the species Agrobacterium tumefaciens.
- Preferred yeasts are Candida, Saccharomyces, Hansenula or Pichia.
- Particularly preferred yeasts are those in which fatty acids/fatty acid derivatives amount to at least 20%, preferably 40%, especially preferably 60% of the cell dry matter, in particular yeasts such as Cryptococcus curvatus (Ratledge (1989) Biotechnology of oils and fats. In: Microbiol lipids Vol.2 Academic Press, London, pp. 567-668).
- Preferred fungi are Aspergillus, Trichoderma, Ashbya, Neurospora, Fusarium, Beauveria, Phytophthora infestans or further fungi described in Indian Chem Engr. Section B. Vol 37, No 1 ,2 (1995), page 15, Table 6.
- fungi in which fatty acids/fatty acid derivatives amount to at least 10%, preferably 20 % of the cell dry matter, in particular Mucor circinelloides and Mortierella alpina (Wynn et al. (2001 ) Microbiology 147: 2857-2864).
- Preferred transgenic organisms are, in particular, plant organisms.
- plant organism encompasses any organism which is capable of photosynthesis and cells, tissues, parts or propagation material (such as seeds or fruit) derived therefrom. Included for the purpose of the invention are all genera and species of higher and lower plants of the plant kingdom. Annual, perennial, monocotyledonous and dicotyledonous plants and gymnosperms are preferred. Included are the mature plant, seeds, shoots and seedlings, and parts derived therefrom, propagation material (for example tubers, seeds or fruit) plant organs, tissues, protoplasts, callus cultures and other cultures, for example cell cultures.
- aliveMature plants refers to plants at any developmental stage beyond the seedling stage. The term seedling refers to a young immature plant at an early developmental stage.
- Plant encompasses all annual and perennial monocotyldedonous or dicotyledonous plants and includes by way of example, but not by limitation, those of the genera Cucurbita, Rosa, Vitis, Juglans, Fragaria, Lotus, Medicago, Onobrychis, Trifolium, Trigonella, Vigna, Citrus, Linum, Geranium, Manihot, Daucus, Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum, Datura, Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia, Digitalis, Majorana, Cichorium, Helianthus, Lactuca, Bromus, Asparagus, Antirrhinum, Hemericallis, Nemesia, Pelargonium, Panicum, Pennisetum, Ranunculus, Senecio, Salpiglossis, Cucumis, Browaalia, Glycine, Pisum, Phaseolus,
- Preferred plants are those from the following plant families: Amaranthaceae, Asteraceae, Brassicaceae, Caryophyllaceae, Chenopodiaceae, Compositae, Cruciferae, Cucurbitaceae, Labiatae, Leguminosae, Papilionoideae, Liliaceae, Linaceae, Malvaceae, Rosaceae, Rubiaceae, Saxifragaceae, Scrophulariaceae, Solanaceae, Sterculiaceae, Tetragoniaceae, Theaceae, Umbelliferae.
- Preferred monocotyledonous plants are selected in particular from the monocotyledonous crop plants such as, for example, the Gramineae family, such as alfalfa, rice, maize, wheat or other cereal species such as barley, millet and sorghum, rye, triticale or oats, and sugar cane, and all grass species.
- the Gramineae family such as alfalfa, rice, maize, wheat or other cereal species such as barley, millet and sorghum, rye, triticale or oats, and sugar cane, and all grass species.
- the invention is applied very particularly preferably to dicotyledonous plant organisms.
- Preferred dicotyledonous plants are selected in particular from the dicotyledonous crop plants such as, for example,
- Asteraceae such as sunflower, tagetes or calendula and others,
- Compositae especially the genus Lactuca, very particularly the species sativa (lettuce) and others,
- Cruciferae particularly the genus Brassica, very particularly the species napus (oilseed rape), campestris (beet), oleracea cv Tastie (cabbage), oleracea cv Snowball Y (cauliflower) and oleracea cv Emperor (broccoli) and other cabbages; and the genus Arabidopsis, very particularly the species thaliana, and cress or canola and others,
- Cucurbitaceae such as melon, pumpkin/squash or zucchini and others
- Leguminosae particularly the genus Glycine, very particularly the species max (soybean), soya, and alfalfa, pea, bean or peanut and others,
- Rubiaceae preferably the subclass Lamiidae such as, for example Coffea arabica or Coffea liberica (coffee bush) and others,
- Sterculiaceae preferably the subclass Dilleniidae such as, for example, Theobroma cacao (cacao bush) and others,
- Theaceae preferably the subclass Dilleniidae such as, for example, Camellia sinensis or Thea sinensis (tea shrub) and others, Umbelliferae, particularly the genus Daucus (very particularly the species carota
- angiosperms such as, for example, Hepaticae (liverworts) and Musci (mosses); pteridophytes such as ferns, horsetail and clubmosses; gymnosperms such as conifers, cycads, ginkgo and Gnetatae, the families of the Rosaceae such as rose, Ericaceae such as rhododendron and azalea, Euphorbiaceae such as poinsettias and croton, Caryophyllaceae such as pinks, Solanaceae such as petunias, Gesneriaceae such as African violet, Balsaminaceae such as touch-me-not, Orchidaceae such as orchids, Iridaceae such as gladioli, iris, freesi
- plant organisms for the purposes of the invention are further organisms capable of being photosynthetically active such as, for example, algae, cyanobacteria and mosses.
- Preferred algae are green algae such as, for example, algae from the genus Haematococcus, Phaedactylum tricornatum, Volvox or Dunaliella. Synechocystis is particularly preferred.
- plants which are suitable for oil production such as, for example, oilseed rape, sunflower, sesame, safflower (Carthamus tinctorius), olive tree, soya, linseed, peanut, castor-oil plant, oil palm, maize, wheat, cocoa bush or various nut species such as, for example, walnut, coconut or almond.
- oilseed rape sunflower, sesame, safflower (Carthamus tinctorius), olive tree, soya, linseed, peanut, castor-oil plant, oil palm, maize, wheat, cocoa bush or various nut species such as, for example, walnut, coconut or almond.
- oilseed rape sunflower
- sesame sesame
- safflower Carthamus tinctorius
- olive tree soya
- linseed peanut
- castor-oil plant oil palm
- maize wheat, cocoa bush
- various nut species such as, for example, walnut, coconut or almond.
- Preferred algae are green algae such as, for example, algae of the genus Haematococcus, Phaedactylum tricornatum, Volvox or Dunaliella. Others which may be mentioned as being preferred are protozoa such as dinoflagellates.
- Preferred among abovementioned organisms are, in particular, those which are naturally capable of synthesizing oils in substantial amounts, such as fungi, e.g. Mucor circinelloides, Mortierella alpina, Pythium insidiosum, yeasts such as Saccharomyces cerevisiae or Cryptococcus curvatus, or plants such as soya, linseed, oilseed rape, coconut, oil palm, safflower, castor-oil plant, peanut, cacao tree or sunflower, especially preferably soya, oilseed rape, sunflower, Mucor circinelloides, Mortierella alpina, Pythium insidiosum, Cryptococcus curvatus or Saccharomyces cerevisiae.
- fungi e.g. Mucor circinelloides, Mortierella alpina, Pythium insidiosum, yeasts such as Saccharomyces cerevisiae or Cryptococcus curvatus
- yeasts such as Sac
- microorganisms are grown in a liquid medium which contains a carbon source, usually in the form of sugars, a nitrogen source, usually in the form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as iron salts, manganese salts, magnesium salts and, if appropriate, vitamins, at temperatures between 0°C and 100°C, preferably between 10°C and 60°C, while passing in oxygen.
- the pH value of the liquid nutrient medium may be kept constant, i.e. can be regulated during culturing or not. Culturing can be effected batchwise, semibatchwise or continuously. Nutrients can be provided at the beginning of the fermentation or fed in semicontinuously or continuously.
- a recombinant expression cassette according to the invention can advantageously be introduced into an organism or into cells, tissues, organs, parts or seeds thereof (preferably into plants or plant cells, tissues, organs, parts or seeds) by using vectors in which the recombinant expression cassettes are present.
- the recombinant expression cassette can be introduced into the vector (for example a plasmid) via a suitable restriction cleavage site.
- the resulting plasmid is first introduced into E.coli. Correctly transformed E.coli are selected, grown, and the recombinant plasmid is obtained by methods with which the skilled worker is familiar. Restriction analysis and sequencing may be used for verifying the cloning step.
- An expression cassette according to the invention can advantageously be introduced into cells, preferably plant cells, using vectors.
- vectors are plasmids, cosmids, phages, viruses or else agrobacteria.
- the expression cassette is introduced by means of plasmid vectors.
- Preferred vectors are those which make possible stable integration of the expression cassette into the host genome.
- Generating a transformed organism requires introducing the DNA, RNA or protein in question into the host cell in question.
- a multiplicity of methods are available for this procedure, which is referred to as transformation (or transduction or transfection) (Keown et al. (1990) Methods in
- the DNA or RNA can be introduced directly by means of microinjection or by bombardment with DNA-coated microparticles.
- the cell can be permeabilized chemically, for example using polyethylene glycol, so that the DNA can enter the cell by diffusion.
- the DNA can also be introduced by protoplast fusion with other DNA-containing units such as minicells, cells, lysosomes or liposomes.
- Another suitable method of introducing DNA is electroporation, where the cells are permeabilized reversibly by an electrical pulse. Such methods are described (Bilang et al. (1991 ) Gene 100:247-250; Scheid et al.
- the desaturases or conjugases can be used for the recombinant modification of a wide range of organisms, preferably of plants, so that these become a de-novo producer of one or more products derived from lipids, such as the two CLA isomers. Plants are initially regenerated after the transformation step and subsequently cultured or grown as usual.
- the plasmid used need not meet any particular requirements. It is possible to use simple plasmids such as those from the pUC series, pBR322, M13mp series, pACYCI 84 and the like. If intact plants are to be regenerated from the transformed cells, the plasmid must contain an additional selectable marker gene.
- transformation may also be effected by bacterial infection by means of Agrobacterium tumefaciens or Agrobacterium rhizogenes. These strains contain a plasmid (Ti and ⁇ i plasmid, respectively) which is transferred to the plant following infection with Agrobaterium. Part of this plasmid, referred to as T-DNA (transferred DNA), is integrated into the genome of the plant cell.
- agrobacterium is also capable of transferring binary vectors (mini-Ti plasmids) to plants, and these vectors are integrated into the plants' genome.
- Agrobacterium-mediated transformation is best suited to dicotyledonous, diploid plant cells, while the direct transformation techniques are suitable for any cell type. Methods for the agrobacterium-mediated transformation are described, for example, by Horsch RB et al. (1985) Science 225:1229f. If agrobacteria are used, the expression cassette is integrated into specific plasmids, namely either into a shuttle vector (intermediate vector) or into a binary vector. If a Ti or Ri plasmid is used for the transformation, at least the right border, but in this case the right and left border, of the Ti or Ri plasmid T-DNA is linked to the expression cassette to be inserted as flanking region.
- Binary vectors are preferably used for transformation with Agrobacterium.
- Binary vectors are capable of replication both in E.coli and in Agrobacterium.
- they contain a selection marker gene and a linker or polylinker flanked by the right and left T-DNA border sequence. They can be transformed directly into Agrobacterium (Holsters et al. (1978) Mol Gen Genet 163:181 -187).
- the selection marker gene which is, for example, the nptll gene, which confers resistance to kanamycin, permits a selection of transformed agrobacteria.
- the agrobacterium which acts as host organism in this case should already contain a plasmid with the vir region. The latter is required for transferring the T-DNA to the plant cells.
- An agrobacterium transformed in this way can be used for transforming plant cells.
- the use of T-DNA for the transformation of plant cells has been studied intensively and described (EP 120 516; Hoekema, In: The Binary Plant Vector System, Offsetdrukkerij Kanters B.V., Alblasserdam, Chapter V; An et al. (1985) EMBO J 4:277-287).
- Various binary vectors are known, some of which are commercially available, such as, for example, pBH 01.2 or pBIN19 (Clontech Laboratories, Inc. USA; Bevan et al.(1984) Nucl Acids Res 12:8711 ), pBinAr, pPZP200 or pPTV.
- the agrobacteria which have been transformed with such a vector can then be used in the known manner for transforming plants, in particular crop plants, such as, for example, oilseed rape, for example by bathing scarified leaves or leaf segments in an agrobacterial solution and subsequently culturing them in suitable media.
- the transformation of plants with agrobacteria is described (White FF, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1 , Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15 - 38; Jenes B et al.(1993) Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1 , Engineering and Utilization, edited by S.D. Kung and R.
- Transgenic plants which contain the above-described desaturase or conjugase, pro-desaturase or conjugase or proOIL nucleic acids or recombinant expression cassettes or vectors according to the invention which are integrated can be regenerated in the known manner from the transformed cells of the scarified leaves or leaf segments.
- Stably transformed cells i.e. those which contain the inserted DNA integrated into the DNA of the host cell, can be selected from untransformed cells when a selectable marker is part of the inserted DNA.
- a selectable marker is part of the inserted DNA.
- any gene which is capable of conferring resistance to antibiotics or herbicides such as kanamycin, G 418, bleomycin, hygromycin or phosphinothricin and the like
- Transformed cells which express such a marker gene are capable of surviving in the presence of concentrations of such an antibiotic or herbicide which kill an untransformed wild type. Examples are mentioned above and preferably comprise the bar gene, which confers resistance to the herbicide phosphinothricin (Rathore KS et al.
- the selection marker permits selection of transformed cells from untransformed cells (McCormick et al. (1986) Plant Cell Reports 5:81 -84).
- the plants obtained can be bred and hybridized in the customary manner. Two or more generations should preferably be grown in order to ensure that the genomic integration is stable and hereditary.
- CLA production means for the purposes of the present invention for example the artificially acquired ability of an increased biosynthesis rate of at least one compound from the group of CLA, its esters, such as, for example, CoA esters or glyceride esters, in the transgenic organism in comparison with the non-genetically-modified starting organism.
- CLA production in the transgenic organism is preferably increased by 10%, especially preferably by 50%, very especially preferably by 100% in comparison with the non-genetically-modified organism.
- Improved may also refer to an advantageously modified qualitative composition of the CLA mixture, i.e. an increased content in (9Z,1 1 E)-CLA and/or (10E,12Z)-CLA in comparison with the starting organism.
- transgenic plant organisms Also in accordance with the invention are cells, cell cultures, parts - such as, for example, roots, leaves and the like in the case of transgenic plant organisms - and transgenic propagation material such as seeds or fruits which are derived from the above-described transgenic organisms.
- the invention furthermore relates to the use of the above-described transgenic organisms according to the invention and to the cells, cell cultures, parts - such as, for example, roots, leaves and the like in the case of transgenic plant organisms - and transgenic propagation material such as seeds or fruits which are derived from them for the production of foodstuffs or feedstuffs, cosmetics or fine chemicals, such as free fatty acids, in particular CLA.
- transgenic plant organisms - and transgenic propagation material such as seeds or fruits which are derived from them for the production of foodstuffs or feedstuffs, cosmetics or fine chemicals, such as free fatty acids, in particular CLA.
- Particularly preferred is the use for the production of CLA- containing lipids, preferably triglycerides.
- Genetically modified plants according to the invention which can be consumed by humans and animals may also be used as foodstuffs or feedstuffs, for example directly or following processing known per se.
- the lipids are obtained in the customary manner.
- the organisms can first be digested post-harvest or else used directly.
- the lipids are advantageously extracted with suitable solvents such as apolar solvents, such as hexane or ethanol, isopropanol or mixtures such as hexane/isopropanol, phenol/chloroform/isoamyl alcohol, at temperatures between 0°C to 80°C, preferably between 20°C and 50°C.
- suitable solvents such as apolar solvents, such as hexane or ethanol, isopropanol or mixtures such as hexane/isopropanol, phenol/chloroform/isoamyl alcohol, at temperatures between 0°C to 80°C, preferably between 20°C and 50°C.
- the biomass is extracted with an excess of solvent, for example with a 1 :4 excess of solvent to biomass.
- the solvent is subsequently removed, for example via distillation
- the crude oil obtained in this manner can subsequently be purified further, for example by removing cloudiness by treatment with polar solvents such as acetone or chloroform, followed by filtration or centrifugation. Further purification over columns is also possible.
- polar solvents such as acetone or chloroform
- the invention furthermore relates to vegetable oils, fatty acid mixtures and/or triglyceride mixtures with an increased content of unsaturated fatty acids, preferably CLA, and which has been produced by the abovementioned processes according to the invention, and to their use for the production of foodstuffs, animal feed, cosmetics or pharmaceuticals. To this end, they are added in customary amounts to the foodstuffs, the animal feed, the cosmetics or pharmaceuticals.
- SEQ ID NO: 1 Nucleic acid sequence encoding an acyl-CoA E1 1 -desaturase from Epiphyas postvittana.
- SEQ ID NO: 2 Protein sequence encoding an acyl-CoA E11 -desaturase from Epiphyas postvittana.
- SEQ ID NO: 3 Nucleic acid sequence encoding an acyl-CoA Z/E1 1 -desaturase from Ostrinia nubilalis.
- SEQ ID NO: 4 Protein sequence encoding an acyl-CoA Z/E1 1 -desaturase from Ostrinia nubilalis.
- SEQ ID NO: 5 Nucleic acid sequence encoding an acyl-CoA Z/E1 1 -desaturase from Ostrinia fumacalis. 6.
- SEQ ID NO: 6 Protein sequence encoding an acyl-CoA Z/E11 -desaturase from Ostrinia furnacalis.
- SEQ ID NO: 7 Nucleic acid sequence encoding an acyl-CoA ⁇ 11 -desaturase from Helicoverpa zea.
- SEQ ID NO: 8 Protein sequence encoding an acyl-CoA ⁇ 11 -desaturase from Helicoverpa zea.
- SEQ ID NO: 9 Nucleic acid sequence encoding an acyl-CoA ⁇ 11 -desaturase from Trichoplusia ni.
- SEQ ID NO: 10 Protein sequence encoding an acyl-CoA ⁇ 11 -desaturase from Trichoplusia ni.
- SEQ ID NO: 11 Nucleic acid sequence encoding an acyl-CoA ⁇ 11 -desaturase from Argyrotaenia velutinana.
- SEQ ID NO: 12 Protein sequence encoding an acyl-CoA ⁇ 11 -desaturase from Argyrotaenia velutinana.
- SEQ ID NO: 13 Nucleic acid sequence encoding an acyl-CoA Z10-desaturase from Planotortrix octo.
- SEQ ID NO: 14 Protein sequence encoding an acyl-CoA Z10-desaturase from Planotortrix octo.
- SEQ ID NO: 15 5'-ATYACHGCCGGKKMYCAYMG-3'
- SEQ ID NO: 16 5'-GGRAABDYGTGRTGGWAGTT-3'
- SEQ ID NO: 17 5'-CCCCAYCRNCTSTGGWCNCA-3'
- SEQ ID NO: 18 5'-CCCTCTAGARTGRRWARTTRTGRWA-3'
- SEQ ID NO: 19 5'-TAATACGACTCACTATAG-3'
- SEQ ID NO: 20 5'-ACATAACTAATTACATGAT-3' 21.
- SEQ ID NO: 21 Nucleic acid sequence encoding an acyl-CoA Z/E1 1- desaturase from Pectinophora gossypiella
- SEQ ID NO: 22 Amino acid sequence encoding an acyl-CoA Z/E11 -desaturase from Pectinophora gossypiella
- cloning steps carried out for the purposes of the present invention such as, for example, restriction cleavages, agarose gel electrophoreses, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking of DNA fragments, transformation of E. coli cells, bacterial culture and sequence analysis of recombinant DNA, are carried out as described by Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6. Oligonucleotides can be synthesized chemically for example in the known manner using the phosphoamidite method (Voet, Voet, 2 nd edition, Wiley Press New York, pp.896-897).
- the cloning steps carried out within the present invention such as, for example, restriction cleavages, agarose gel electrophosesis, purification of DNA fragments, transfer of nucleic acids to vitrocellulose and nylon membranes, linking DNA fragments, transformation of E. coli cells, bacterial cultures, propagation of phages and sequence analysis of recombinant DNA were carried out as described by Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6. Recombinant DNA molecules were sequenced using a laser fluorescence DNA sequencer from Licor (sold by MWG Biotech, Ebersbach) following the method of Sanger (Sanger et al. (1977) Proc Natl Acad Sci USA 74:5463-5467).
- Example 1 Breeding the Lepidoptera insects
- insects are kept on suitable host plants in terrarria.
- the growth conditions are: 27°C, day-night rhythm: 14 h light, 10 hours darkness.
- Insects and larvae are transferred to fresh plants twice per week.
- Puppae are collected, and males and females are kept separately in terrarria until the adult insects hatch. Approximately 1 to 2 days after the insects have hatched, the pheromone glands can be isolated.
- Example 2 Isolation of desaturase or conjugase cDNAs by means of degenerate primers
- RNA is isolated from the abdomen of adult moths and frozen in liquid N 2 until total RNA is isolated, for example by means of TRIzol (Gibco/BRL) following the manufacturer's instructions.
- TRIzol Gibco/BRL
- RNA is employed to produce a first-strand cDNA with an oligo(dT) primer. This may be done for example using the SMART RACE cDNA amplification kit (Clontech) following the manufacturer's instructions.
- This single-strand cDNA acts as template for a PCR in which the central region of the desaturase/ conjugase cDNA is amplified.
- Two degenerate primers are designed in such a way that they are capable of amplifying the conserved central region of the desaturases/conjugases from lepidopterans and employed in the following PCR protocol:
- the degenerate primers with SEQ ID NO: 10 and SEQ ID NO: 11 are used as primer pair for the amplification of the central desaturase region.
- the PCR was carried out under the following cycle conditions:
- the PCR product is ligated directly, for example into the linearized TOPO TA PCR 2.1 vector (Invitrogen) and subsequently transformed into competent E.coli TOP 10 cells (Invitrogen). Positive colonies are reamplified, the plasmid DNA is purified (Qiagen Plasmid Mini Kit) and subsequently sequenced. Owing to the sequence information obtained, gene-specific primers can be derived and used for amplifying 5' and 3' regions (SMART RACE cDNA Amplification Kit (Clontech)). Again, these PCR products are ligated into the TOPO TA PCR 2.1 vector (Invitrogen) and subsequently transformed into competent TOP 10 cells (Invitrogen). Positive colonies are reamplified, and the plasmid DNA is purified (Qiagen Plasmid Mini Kit) and subsequently sequenced.
- the complete sequence of a desaturase/conjugase can be put together using standard cloning techniques and transferred for characterization purposes for example into the pYES2 vector (Invitrogen) for expression in yeast.
- Saccharomyces INVSd (Invitrogen) are transformed with the corresponding pYES2 expression vectors by means of a modified PEG/lithium acetate protocol (Ausubel et al. (1996) Current Protocols in Molecular Biology. John Wiley and Sons, New York).
- pYES2DESAT transformants pYES2DESATa-d
- one pYES2 transformant are selected for further cultivation and functional expression.
- Preculture 20 ml of CMdum liquid medium supplemented with 2% (w/v) raffinose were inoculated with the transgenic yeast clones (pYES2DESATa-d, pYES2) and cultured for 3 days at 30°C, 200 rpm, until an optical density at 600 nm (OD 60 o) of 1.5-2 had been reached.
- CMdum liquid medium supplemented with 2% of raffinose and 1% (v/v) Tergitol NP-40 were concentrated with the corresponding substrates such as stearic acid, palmitic acid or myristic acid, to a final concentration of 0.003% (w/v).
- the media were inoculated with the precultures to an OD 6 oo of 0.05.
- Expression was induced for 16 hours at an OD 600 of 0.2 using 2% (w/v) galactose, whereafter the cultures had reached an OD 600 of 0.8 to 1.2.
- Fatty acid analysis The total fatty acids were extracted from yeast cultures and analyzed by means of gas chromatography. To this end, cells of 5 ml of culture were harvested by centrifugation (1000 x g, 10 min, 4°C) and washed once with 100 mM NaHC03, pH 8.0 in order to remove residues of medium and fatty acids. To prepare the fatty acid methyl esters (FAMES), the cell sediments were shock-frozen in liquid N 2 and lyophilized at 30°C under N 2 gas. The pellet is homogenized in 1 % sodium methoxide in methanol and the homogenate is incubated for 20 minutes at room temperature.
- Equal volumes of 1 M NaCI and n-heptane are subsequently added, the sample is mixed and the mixture is transferred into a GC tube.
- the samples are separated from a DB-wax capillary column (30 m, 0.25 mm, 0.25 ⁇ m; Agilent J & W) in a Hewlett Packard 6890 gas chromatograph equipped with a flame ionization detector.
- the oven temperature was programmed from 60°C (hold 5 min) to 200°C at a rate of 20°C/min (hold 20 min) and finally to 250°C (hold 30 min) at a rate of 20°C/min.
- the carrier gas used was nitrogen (1.6 ml/min).
- the fatty acids were identified by comparison with retention times of FAME standards (SIGMA).
- the following fatty acids are preferably used as standard for this purpose: c9-16:1 , t9-16:1 , 18:0, c9-18:1 , t9- 18:1 , d 1 -18:1 , t11 -18:1 , c9,d 2-18:2, t9,t12-18:2, c9,t1 1 -18:2, t10,c12-18:2.
- Example 4 Expression cloning of desaturase/conjugase from Lepidoptera in Saccharomyces cerevisiae
- RNA The pheromone glands are isolated from the abdomen of adult moths and frozen in liquid N 2 until total RNA is isolated, for example by means of TRIzol (Gibco/BRL) following the manufacturer's instructions. Experience has shown that approximately 60 to 80 ⁇ g of total RNA can be isolated from approximately 30 mg fresh tissue. Approximately 5 ⁇ g of total RNA is employed for generating a cDNA library. This may be done for example using the SMART cDNA Library Construction Kit (Clontech). The isolated double-stranded cDNA is finally ligated into the linearized pYES2 (Invitrogen) yeast expression vector.
- TRIzol Gibco/BRL
- the multiple cloning site of the pTriplEx2 vector (Clontech) is first inserted into pYES2.
- the double-stranded cDNA is digested with SfilA and SfilB and then cloned in a directed fashion into the vector which has been modified.
- plasmid DNA is transformed into INVSd (Invitrogen) using the Saccharomyces cerevisiae EASY COMP Transformation kit (Invitrogen) following the manufacturer's instructions.
- INVSd Invitrogen
- Saccharomyces cerevisiae EASY COMP Transformation kit Invitrogen
- Two 50 ⁇ l-batches are plated onto selection medium in a large square Petri dish (245x245 mm) and incubated for 3 days at 30°C.
- MTP microtiter plates
- the preculture is carried out in 200 ⁇ of medium [1 x CSM-Ura; 1 x YNB without amino acids and sugar; 0.5% raffinose; 5% glycerol; 40 mg / 1 adenin sulfate; 0.5% ammonium sulfate] for 72 hours at 30°C and 250 revolutions per minute.
- An OD 6 oo of 0.2 is adjusted in the main culture by addition of an average volume from the preculture.
- the main culture is carried out in 1 ml of medium [1 x CSM-Ura; 1 x YNB without amino acids and sugar; 0.5% raffinose; 2% galactose; 0.2% Tergitol NP-40; 40 mg/l adenin sulfate; 0.5% ammonium sulfate; 0.3 mM fatty acid substrate] for 2 to 3 weeks at 16°C and 250 revolutions per minute until an OD 600 of 3 to 4 has been reached.
- medium [1 x CSM-Ura; 1 x YNB without amino acids and sugar; 0.5% raffinose; 2% galactose; 0.2% Tergitol NP-40; 40 mg/l adenin sulfate; 0.5% ammonium sulfate; 0.3 mM fatty acid substrate] for 2 to 3 weeks at 16°C and 250 revolutions per minute until an OD 600 of 3 to 4 has been reached.
- the yeast cells are sedimented (1000 x g, 10 min, 4°C) and stored at -80°C until further processing.
- FMES fatty acid methyl esters
- the cell sediments are shock-frozen in liquid N 2 and lyophilized under N 2 gas at 30°C.
- the pellet is homogenized in 1 % sodium methoxide in methanol and incubated for 20 minutes at room temperature. Equal volumes of 1 M NaCI and n-heptane are subsequently added, the samples are mixed and the supernatant is transferred into a GC tube.
- the samples are separated on a DB-wax capillary column (30 m, 0.25 mm, 0.25 ⁇ m; Agilent J & W) in a Hewlett Packard 6890 gas chromatograph equipped with a flame ionization detector.
- the oven temperature was programmed from 60°C (hold 5 min) to 200°C at a rate of 20°C/min (hold 20 min) and finally to 250°C (hold 30 min) at a rate of 20°C/min.
- the carrier gas used was nitrogen (1.6 ml/min).
- the fatty acids were identified by comparison with retention times of FAME standards (SIGMA). The same standards as listed in Example 3 are used.
- STE buffer [2% SDS; 50 mM Tris/HCI, pH 8.0; 10 mM EDTA] are added to the cell lysate and the mixture is incubated for 10 minutes at room temperature.
- 200 ⁇ l of 5 M sodium acetate are added and the mixture is placed on ice for 30 minutes. After centrifugation, the supernatant is transferred and precipitated with 2.5 volumes of ethanol. The pellet which has sedimented is washed with 70% ethanol and finally taken up in sterile water.
- sequence of the desaturase/conjugase can be determined by sequencing using vector-specific primers (SEQ ID NO: 12 and 13).
- Example 5 Manipulation of the plant fatty acid biosynthesis
- transgenic A.thaliana or B.napus plants which express the desaturases/conjugases from lepidopterans
- pBinAR H ⁇ fgen and Willmitzer (1990) Plant Sci 66:221 -230.
- This vector contains the CaMV (cauliflower mosaic virus) 35S promoter (Franck et al. (1980) Cell 21 (1 ):285-294) and the termination signal of the octopine synthase gene (Gielen et al. (1984) EMBO J 3:835-846).
- Agroabacterium tumefaciens strain (GV3101 [pMP90]) on the basis of a modified vacuum infiltration method (Clough S and Bent A (1998) Plant J 16(6):735-43; Bechtold N et al. (1993) in: Planta Agrobacterium-mediated gene transfer by infiltration of adult Arabidopsis thaliana plants. CRAcad Sci Paris 1 144(2):204-212).
- the Agrobacterium tumefaciens cells which were used had previously been transformed with the plasmids.
- Seeds of the primary transformants are selected on the basis of their resistance to antibiotics. Seedlings with resistance to antibiotics are planted into soil and subjected to biochemical analysis as fully-developed plants.
- Transgenic oilseed rape plants are generated following a protocol of Bade JB and Damm B (in Gene Transfer to Plants, Potrykus I and Spangenberg G (eds.) Springer Lab Manual, Springer Verlag, 1995, 30-38), which also states the composition of the media and buffers used.
- the transformations are carried out with Agrobacterium tumefaciens strain GV3101 [pMP90].
- the plasmids pBinAR-TkTP/Vit E-AT are used for the transformation.
- Seeds of Brassica napus var. Westar are surface-sterilized with 70% ethanol (v/v), washed for 10 minutes in water at 55°C, incubated for 20 minutes in 1 % strength hypochlorite solution (25% v/v Teepol, 0.1 % v/v Tween 20) and washed six times with sterile water for in each case 20 minutes.
- the seeds are dried for three days on filter paper, and 10 to 15 seeds are germinated in a glass flask containing 15 ml of germination medium.
- the roots and apices are removed from several seedlings (approximate size 10 cm), and the hypocotyls which remain are cut into pieces approximately 6 mm in length.
- the approx. 600 explants thus obtained are washed for 30 minutes with 50 ml of basal medium and transferred into a 300 ml flask. After addition of 100 ml of callus induction medium, the cultures are incubated for 24 hours at 100 rpm.
- An overnight culture of the Agrobacterium strain is established at 29°C in Luria broth medium supplemented with kanamycin (20 mg/l), and 2 ml of this culture are incubated in 50 ml of Luria broth medium without kanamycin for 4 hours at 29°C until an OD 6 oo of 0.4 to 0.5 has been reached. After the culture has been pelleted for 25 minutes at 2000 rpm, the cell pellet is resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution is brought to an OD 60 o of 0.3 by addition of further basal medium.
- the callus induction medium is removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution are added, and the culture is mixed carefully and incubated for 20 minutes.
- the agrobacterial suspension is removed, the oilseed rape explants are washed for 1 minute using 50 ml of callus induction medium, and 100 ml of callus induction medium are subsequently added.
- Coculturing is performed for 24 hours on a orbital shaker at 100 rpm. Coculturing is stopped by withdrawing the callus induction medium, and the explants are washed twice for in each case 1 minute with 25 ml and twice for 60 minutes with in each case 100 ml of wash medium at 100 rpm.
- the wash medium together with the explants is transferred to 15 cm Petri dishes, and the medium is removed using sterile pipettes.
- batches of 20 to 30 explants are transferred into 90 mm Petri dishes which contain 25 ml of shoot induction medium supplemented with kanamycin.
- the Petri dishes are filled with 2 layers of Leukopor and incubated at 25°C and 2000 lux at a 16-hour light/8-hour darkness photo period. Every 12 days, the developing calli are transferred to fresh Petri dishes containing shoot induction medium. All further steps for regenerating intact plants are carried out as described by Bade, J.B and Damm, B. (in: Gene Transfer to Plants, Potrykus I and Spangenberg G (eds.) Springer Lab Manual, Springer Verlag, 1995, 30-38).
- the seeds of transgenic plants are homogenized directly in 1 % sodium methoxide in methanol and the homogenate is incubated for 20 minutes at room temperature. Equal volumes of 1 M NaCI and n-heptane are subsequently added, the sample is mixed and the supernatant is transferred into a GC tube. The samples are separated on a DB-wax capillary column (30 m, 0.25 mm, 0.25 ⁇ m; Agilent J & W) in a Hewlett Packard 6890 gas chromatograph equipped with a flame ionization detector.
- the oven temperature was programmed from 60°C (hold 5 min) to 200°C at a rate of 20°C/min (hold 20 min) and finally to 250°C (hold 30 min) at a rate of 20°C/min.
- the carrier gas used was nitrogen (1.6 ml/min).
- the fatty acids were identified by comparison with retention times of FAME standards (SIGMA). The same standards as stated in Example 3 are used.
- Example 6 Functional expression in yeast of a desaturase from the Lepidoptera Pectinophora gossypiella
- a desaturase isolated from gland material of the moth Pectinophora gossypiella was cloned into the yeast expression vector pYES2 (Invitrogen) by means of BamHI and EcoRI.
- the resulting construct was named pYES2::DesPgos.
- Both pYES2::DesPgos and the control pYES2 were transformed into yeast cells (Saccharomyces cerevisiae INVSd [MAT, his3-1 , Ieu2, trp1 -289, ura3-52]; Invitrogen) using the S.c. Easy Comp Transformation Kit (Invitrogen).
- yeast cells contained additionally the construct pESC::ACS for expressing a Brassica napus acetyl-CoA synthase.
- pESC :ACS for expressing a Brassica napus acetyl-CoA synthase.
- a single colony of both pYES2::DesPgos and of the control pYES2 was isolated on selection medium and grown for 2 days at 30°C and 200 revolutions per minute in 50 ml of preculture medium (1 * CSM -Leu ⁇ Ura; 1 * YNB w/o AA; 0.5% raffinose; 5% glycerol and 0.5% ammonium sulfate) to give a preculture.
- the main cultures were adjusted to OD ⁇ 2 , and 10 ml were centrifuged for 30 minutes at RT and 17500 g.
- the pellet was resuspended in H 2 0, heated for 10 minutes at 90°C and again sedimented under the same conditions.
- the pellet was washed with H 2 0, sedimented, shock-frozen in liquid nitrogen (N 2 ) and subsequently lyophilized under N 2 .
- N 2 liquid nitrogen
- FAME fatty acid methyl esters
- Table 1 shows the relative distribution of the FAME of lipids from pYES2::DesPgos in comparison with the control pYES2 at 16°C. It can be seen that the expression of the Pectinophora gossypiella desaturase results in an accumulation of the following monounsaturated fatty acids: C16:1 D11 , C18:1 D11 and C18:1 D13. Moreover, the heterologous expression of the P. gossypiella desaturase leads to the formation of (9Z,1 1 E)-CLA.
- Table 2 shows the relative distribution of the FAME of lipids of pYES2::DesPgos in comparison with the control pYES2 at 30°C.
- the expression results at 30°C correspond to those at 16°C: expression of the Pectinophora gossypiella desaturase in the yeast leads to an accumulation of the monounsaturated fatty acids C16:1 D1 1 , C18:1 D1 1 and C18:1 D13.
- the heterologous expression of the P. gossypiella desaturase leads to the formation of (9Z,11 E)-CLA.
- Table 1 Heterologous expression of the Pectinophora gossypiella desaturase in S. cerevisiae at 16°C.
- the values represent the relative amount of the individual fatty acids in the total fatty acid spectrum.
- Table 2 Heterologous expression of the Pectinophora gossypiella desaturase in S. cerevisiae at 30°C.
- the values represent the relative amount of the individual fatty acids in the total fatty acid spectrum.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Cette invention concerne des méthodes de production d'acides gras insaturés, de préférence des acides gras polyinsaturés conjugués, tels que l'acide linoléique conjugué (CLA), par expression recombinante de désaturases provenant d'insectes de l'ordre des lépidoptères. Cette expression intervient, de préférence, dans un organisme choisi parmi des organismes végétaux, des levures, des champignons ou des algues. L'invention concerne également des cassettes d'expression recombinante servant à l'expression recombinante de désaturases provenant d'insectes de l'ordre des lépidoptères. Elle concerne en outre les organismes transgéniques transformés à l'aide de ces cassettes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10208812A DE10208812A1 (de) | 2002-03-01 | 2002-03-01 | Verfahren zur Herstellung von ungesättigten Fettsäuren |
DE10208812 | 2002-03-01 | ||
PCT/US2003/005788 WO2003074715A2 (fr) | 2002-03-01 | 2003-02-27 | Methode de production d'acides gras insatures |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1527182A2 true EP1527182A2 (fr) | 2005-05-04 |
EP1527182A4 EP1527182A4 (fr) | 2005-12-21 |
Family
ID=27740519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03716183A Withdrawn EP1527182A4 (fr) | 2002-03-01 | 2003-02-27 | Methode de production d'acides gras insatures |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1527182A4 (fr) |
JP (1) | JP2006503546A (fr) |
CN (1) | CN1656226A (fr) |
AU (2) | AU2003208769A1 (fr) |
BR (1) | BR0307938A (fr) |
CA (1) | CA2477858A1 (fr) |
DE (1) | DE10208812A1 (fr) |
WO (2) | WO2003074715A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06009572A (es) * | 2004-02-27 | 2007-05-23 | Basf Plant Science Gmbh | Metodo para la produccion de acidos grasos poliinsaturados en plantas transgenicas. |
DE102005052551A1 (de) * | 2005-11-02 | 2007-05-16 | Rothamsted Res Harpenden | Verfahren zur Herstellung von y-Linolensäure und/oder Stearidonsäure in transgenen Brassicaceae und Linaceae |
RU2442793C2 (ru) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ |
KR101667623B1 (ko) | 2005-11-30 | 2016-10-19 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
BRPI0717474A2 (pt) * | 2006-10-20 | 2014-03-11 | Arizona Board Of Regentes For And On Behalf Of Arizona State University | Cianobactéria modificada |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
JP5833446B2 (ja) * | 2008-12-01 | 2015-12-16 | ユニヴェルシタット・デス・ザールラント | 粘液細菌によるオメガ−3脂肪酸の生成 |
JP5168511B2 (ja) * | 2009-08-25 | 2013-03-21 | 独立行政法人農業生物資源研究所 | 種子特異的プロモーターおよびその利用 |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
US11236351B2 (en) | 2010-05-17 | 2022-02-01 | Dow Agrosciences Llc | Production of DHA and other LC PUFAs in plants |
EP3533803B1 (fr) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anticorps anti-bêta-amyloïde |
TW201307553A (zh) | 2011-07-26 | 2013-02-16 | Dow Agrosciences Llc | 在植物中生產二十二碳六烯酸(dha)及其他長鏈多元不飽和脂肪酸(lc-pufa)之技術 |
KR101540746B1 (ko) | 2011-12-28 | 2015-08-03 | 대한민국 | 공액리놀레산(Conjugated Linoleic Acid, CLA)의 생산방법 |
CN108138202B (zh) | 2015-06-26 | 2023-05-16 | 丹麦科技大学 | 用于在酵母中产生蛾信息素的方法 |
BR112018010108A2 (pt) * | 2015-11-18 | 2018-11-21 | Provivi Inc | micro-organismos para a produção de ferormônios de inseto e compostos relacionados |
US11214818B2 (en) | 2016-06-06 | 2022-01-04 | Provivi, Inc. | Semi-biosynthetic production of fatty alcohols and fatty aldehydes |
ES2930358T3 (es) | 2016-12-16 | 2022-12-09 | Univ Danmarks Tekniske | Producción de alcoholes grasos desaturados y acetatos de acilo grasos desaturados en levaduras |
US11345922B2 (en) | 2016-12-16 | 2022-05-31 | Danmarks Tekniske Universitet | Methods for producing fatty alcohols and derivatives thereof in yeast |
BR112019024258A2 (pt) | 2017-05-17 | 2020-08-18 | Provivi, Inc. | Microorganismos yarrowia lipolytica recombinante e método para produzir um c6-c24 álcool graxo mono- ou poliinsaturado a partir de uma fonte endógena ou exógena de c6-c24 ácidograxo saturado |
EP3521439A1 (fr) * | 2018-01-31 | 2019-08-07 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Procédé de production de triacylglycérides et d'acides gras |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064616A2 (fr) * | 1998-06-12 | 1999-12-16 | Abbott Laboratories | Acides gras polyinsatures dans des plantes |
WO2000011012A1 (fr) * | 1998-08-24 | 2000-03-02 | Rutgers, The State University Of New Jersey | Gene synthetique de desaturases d'acides gras destine a l'expression chez les vegetaux |
WO2001002591A1 (fr) * | 1999-07-06 | 2001-01-11 | Basf Plant Science Gmbh | Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures |
WO2001092489A2 (fr) * | 2000-05-26 | 2001-12-06 | Washington State University Research Foundation | Gene desaturase palmitate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0866874T4 (da) * | 1995-11-14 | 2005-07-11 | Loders Croklaan Bv | Fremgangsmåde til fremstilling af materialer med höjt indhold af isomerer af konjugeret linolsyre |
US5876994A (en) * | 1995-11-16 | 1999-03-02 | Cornell Research Foundation, Inc. | Pheromone desaturases |
IL128165A0 (en) * | 1997-05-05 | 1999-11-30 | Dow Agrosciences Llc | Insecticidal protein toxins from xenorhabdus |
US6410761B1 (en) * | 1998-03-17 | 2002-06-25 | Conlinco, Inc. | Conjugated linoleic acid compositions and methods of making same |
US6706501B1 (en) * | 1999-06-30 | 2004-03-16 | Arkion Life Sciences Llc | Polynucleotide encoding a propionibacterium linoleate isomerase and uses thereof |
-
2002
- 2002-03-01 DE DE10208812A patent/DE10208812A1/de not_active Withdrawn
-
2003
- 2003-02-27 WO PCT/US2003/005788 patent/WO2003074715A2/fr active Application Filing
- 2003-02-27 JP JP2003573162A patent/JP2006503546A/ja active Pending
- 2003-02-27 AU AU2003208769A patent/AU2003208769A1/en not_active Abandoned
- 2003-02-27 CN CNA038050625A patent/CN1656226A/zh active Pending
- 2003-02-27 BR BR0307938-4A patent/BR0307938A/pt not_active IP Right Cessation
- 2003-02-27 AU AU2003219899A patent/AU2003219899A1/en not_active Abandoned
- 2003-02-27 EP EP03716183A patent/EP1527182A4/fr not_active Withdrawn
- 2003-02-27 WO PCT/EP2003/002011 patent/WO2003074716A2/fr not_active Application Discontinuation
- 2003-02-27 CA CA002477858A patent/CA2477858A1/fr not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999064616A2 (fr) * | 1998-06-12 | 1999-12-16 | Abbott Laboratories | Acides gras polyinsatures dans des plantes |
WO2000011012A1 (fr) * | 1998-08-24 | 2000-03-02 | Rutgers, The State University Of New Jersey | Gene synthetique de desaturases d'acides gras destine a l'expression chez les vegetaux |
WO2001002591A1 (fr) * | 1999-07-06 | 2001-01-11 | Basf Plant Science Gmbh | Plantes exprimant des genes de la δ6-desaturase; huiles contenant des acides gras polyinsatures extraites de ces plantes et procede de production d'acides gras insatures |
WO2001092489A2 (fr) * | 2000-05-26 | 2001-12-06 | Washington State University Research Foundation | Gene desaturase palmitate |
Non-Patent Citations (4)
Title |
---|
LIU WEITIAN ET AL: "Cloning and functional expression of a cDNA encoding a metabolic acyl-CoA DELTA9-desaturase of the cabbage looper moth, Trichoplusia ni" INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 29, no. 5, May 1999 (1999-05), pages 435-443, XP002341751 ISSN: 0965-1748 * |
LIU WEITIAN ET AL: "Gene characterized for membrane desaturase that produces (E)-11 isomers of mono- and diunsaturated fatty acids" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 99, no. 2, 22 January 2002 (2002-01-22), pages 620-624, XP002252845 ISSN: 0027-8424 * |
ROSENFIELD CLAIRE-LISE ET AL: "Structural and functional conservation and divergence among acyl-CoA desaturases of two noctuid species, the corn earworm, Helicoverpa zea, and the cabbage looper, Trichoplusia ni" INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 31, no. 10, September 2001 (2001-09), pages 949-964, XP002341750 ISSN: 0965-1748 * |
See also references of WO03074715A2 * |
Also Published As
Publication number | Publication date |
---|---|
CA2477858A1 (fr) | 2003-09-12 |
JP2006503546A (ja) | 2006-02-02 |
WO2003074716A3 (fr) | 2003-12-24 |
DE10208812A1 (de) | 2003-09-11 |
EP1527182A4 (fr) | 2005-12-21 |
WO2003074715A3 (fr) | 2004-04-29 |
BR0307938A (pt) | 2005-01-11 |
AU2003219899A1 (en) | 2003-09-16 |
WO2003074716A2 (fr) | 2003-09-12 |
AU2003208769A1 (en) | 2003-09-16 |
AU2003208769A8 (en) | 2003-09-16 |
CN1656226A (zh) | 2005-08-17 |
WO2003074715A2 (fr) | 2003-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003245878B2 (en) | Methods for increasing oil content in plants | |
US7700833B2 (en) | Process for the production of unsaturated fatty acids | |
EP1618193B1 (fr) | Utilisation de genes pour augmenter la teneur en huile dans les plantes | |
WO2003074715A2 (fr) | Methode de production d'acides gras insatures | |
AU2003296638B2 (en) | Method for the production of polyunsaturated fatty acids | |
US7465850B2 (en) | Use of a gene for increasing the oil content in plants | |
CA2591599A1 (fr) | Procede de production d'acides gras a longues chaines multi-insatures dans des organismes transgeniques | |
CA2658273A1 (fr) | Procede de fabrication d'acide arachidonique et/ou d'acide eicosapentaenoique dans des plantes | |
CN101300357B (zh) | 在转基因芸苔科和亚麻科植物中生产γ-亚麻酸和/或十八碳四烯酸的方法 | |
US20090083882A1 (en) | Method for increasing the total oil content in oil plants | |
US20070022497A1 (en) | Trans-2-enoyl-coa reductase gene of euglena gracilis | |
Napier et al. | Method For The Production Of Gamma-linolenic Acid And/or Stearidonic Acid In Transgenic Brassicaceae And Linaceae (Patent US 2008/0229454 A1) | |
Napier et al. | Delta 6 Desaturases From Primulaceae, Expressing Plants And Pufa-containing Oils (Patent US 2009/0222955 A1) | |
Napier | Delta 6-desaturases From Primulaceae, Expressing Plants And Pufa-containing Oils (Patent WO 2003/072784 A1) | |
Napier et al. | Novel Method For The Production Of Polyunsaturated Fatty Acids (Patent US 2006/0246556 A1) | |
CA2541141A1 (fr) | Gene de la trans-2-enoyl-coa reductase de l'euglena gracilis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041029 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051107 |
|
17Q | First examination report despatched |
Effective date: 20061117 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080408 |